1
|
Qin A, Wang M, Yang H, Xin T, Xu L. Chinese-modified MIND Diet and subjective well‑being in adults aged 60 years or older in China: a national community-based cohort study. Eur J Nutr 2024:10.1007/s00394-024-03484-x. [PMID: 39231869 DOI: 10.1007/s00394-024-03484-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2024] [Accepted: 08/27/2024] [Indexed: 09/06/2024]
Abstract
OBJECTIVE Observing the dietary principles of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has exhibited an association with a diminished occurrence of diverse ailments, enhanced mental well-being, and extended longevity. Nevertheless, current literature is deficient in terms of investigating the link between the MIND diet and subjective well-being (SWB) specifically in older adults. Hence, this study endeavors to examine the correlation between adhering to a Chinese-modified Mediterranean-DASH Intervention for Neurodegenerative Delay (cMIND) diet and SWB in the older Chinese adults, taking into account the unique dietary attributes of the Chinese population. METHODS Using data from the latest four waves of the Chinese Longitudinal Healthy Longevity Survey. Multiple linear regression and multinomial ordered logistic regression were employed to examine the relationship between the duration of adherence to cMIND diet and SWB in Chinese older adults. RESULTS The results indicated a significant association between the duration of adherence to cMIND diet and SWB (1 ∼ 6 years: B = 0.907, 95%CI = 0.508 ∼ 1.307, P < 0.001; 7 ∼ 9 years: B = 1.286, 95%CI = 0.767 ∼ 1.805, P < 0.001; 10 years and above: B = 2.320, 95%CI = 1.677 ∼ 2.963, P < 0.001). The longer the duration of adherence to cMIND diet, the higher the scores for life satisfaction (B = 0.184, 95%CI = 0.110 ∼ 0.259; B = 0.312, 95%CI = 0.217 ∼ 0.407; B = 0.321, 95%CI = 0.193 ∼ 0.448), positive affect (B = 0.434, 95%CI = 0.209 ∼ 0.658; B = 0.701, 95%CI = 0.400 ∼ 1.003; B = 1.167, 95%CI = 0.775 ∼ 1.559), and negative affect (B = 0.289, 95%CI = 0.078 ∼ 0.500; B = 0.832, 95%CI = 0.479 ∼ 1.185), suggesting a higher SWB score. Sensitivity analysis further supports our findings. CONCLUSION Considering the poor knowledge, attitudes, and behaviors related to diet among Chinese adults, especially older adults, it is imperative to implement dietary policies that promote SWB in older adults to enhance their happiness in later life.
Collapse
Affiliation(s)
- Afei Qin
- Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 WenhuaxiRoad, Jinan, 250012, Shandong, China
- Key Laboratory of Health Economics and Policy Research, National Health Commission (NHC), Shandong University), Jinan, 250012, Shandong, China
- Center for Health Economics Experiment and Public Policy Research, Shandong University, Jinan, 250012, Shandong, China
| | - Meiqi Wang
- Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 WenhuaxiRoad, Jinan, 250012, Shandong, China
- Key Laboratory of Health Economics and Policy Research, National Health Commission (NHC), Shandong University), Jinan, 250012, Shandong, China
| | - Haifeng Yang
- Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 WenhuaxiRoad, Jinan, 250012, Shandong, China
- Key Laboratory of Health Economics and Policy Research, National Health Commission (NHC), Shandong University), Jinan, 250012, Shandong, China
- Center for Health Economics Experiment and Public Policy Research, Shandong University, Jinan, 250012, Shandong, China
| | - Tianjiao Xin
- Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 WenhuaxiRoad, Jinan, 250012, Shandong, China
- Key Laboratory of Health Economics and Policy Research, National Health Commission (NHC), Shandong University), Jinan, 250012, Shandong, China
- Center for Health Economics Experiment and Public Policy Research, Shandong University, Jinan, 250012, Shandong, China
| | - Lingzhong Xu
- Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 WenhuaxiRoad, Jinan, 250012, Shandong, China.
- Key Laboratory of Health Economics and Policy Research, National Health Commission (NHC), Shandong University), Jinan, 250012, Shandong, China.
- Center for Health Economics Experiment and Public Policy Research, Shandong University, Jinan, 250012, Shandong, China.
| |
Collapse
|
2
|
van Zonneveld SM, van den Oever EJ, Haarman BCM, Grandjean EL, Nuninga JO, van de Rest O, Sommer IEC. An Anti-Inflammatory Diet and Its Potential Benefit for Individuals with Mental Disorders and Neurodegenerative Diseases-A Narrative Review. Nutrients 2024; 16:2646. [PMID: 39203783 PMCID: PMC11357610 DOI: 10.3390/nu16162646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2024] [Revised: 08/07/2024] [Accepted: 08/08/2024] [Indexed: 09/03/2024] Open
Abstract
This narrative review synthesizes current evidence regarding anti-inflammatory dietary patterns and their potential benefits for individuals with mental disorders and neurodegenerative diseases. Chronic low-grade inflammation is increasingly recognized as a key factor in the etiology and progression of these conditions. The review examines the evidence for the anti-inflammatory and neuroprotective properties of dietary components and food groups, focusing on whole foods rather than specific nutrients or supplements. Key dietary components showing potential benefits include fruits and vegetables (especially berries and leafy greens), whole grains, legumes, fatty fish rich in omega-3, nuts (particularly walnuts), olive oil, and fermented foods. These foods are generally rich in antioxidants, dietary fiber, and bioactive compounds that may help modulate inflammation, support gut health, and promote neuroprotection. Conversely, ultra-processed foods, red meat, and sugary beverages may be harmful. Based on this evidence, we designed the Brain Anti-Inflammatory Nutrition (BrAIN) diet. The mechanisms of this diet include the modulation of the gut microbiota and the gut-brain axis, the regulation of inflammatory pathways, a reduction in oxidative stress, and the promotion of neuroplasticity. The BrAIN diet shows promise as an aid to manage mental and neurodegenerative disorders.
Collapse
Affiliation(s)
- Sophie M. van Zonneveld
- Department of Biomedical Sciences, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Ellen J. van den Oever
- Department of Biomedical Sciences, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Benno C. M. Haarman
- Department of Psychiatry, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Emmy L. Grandjean
- Department of Biomedical Sciences, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Jasper O. Nuninga
- Department of Biomedical Sciences, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| | - Ondine van de Rest
- Department of Human Nutrition and Health, Wageningen University & Research, 6708 WE Wageningen, The Netherlands
| | - Iris E. C. Sommer
- Department of Biomedical Sciences, Cognitive Neuroscience Center, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
- Department of Psychiatry, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands
| |
Collapse
|
3
|
Hatami A, Ahmadi-Khorram M, Keykhaei F, Hashemi M, Javid R, Hashempour M, Esfehani AJ, Nematy M. Dietary acid load as well as dietary phytochemical index, and association with multiple sclerosis: results from a case-control study. BMC Nutr 2024; 10:93. [PMID: 38951946 PMCID: PMC11218216 DOI: 10.1186/s40795-024-00897-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Accepted: 06/19/2024] [Indexed: 07/03/2024] Open
Abstract
INTRODUCTION Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions. Although the etiology and pathogenesis of MS remains unclear, nutrition is among the environmental factors that may be involved in developing MS. Currently, no specific diet has been associated with MS. This study aimed to investigate the relationship between the dietary phytochemical index (DPI), dietary acid load (DAL), and the risk of developing MS. METHODS This case‒control study was conducted on 174 patients with MS and 171 healthy individuals in Mashhad, Iran. Data were collected using a 160-item semiquantitative food frequency questionnaire (FFQ). The study investigated the association between DPI, DAL, and MS, considering anthropometric measures, dietary intake, smoking habits, and sex. DPI, potential renal acid load (PRAL), and net endogenous acid production (NEAP), as indicators of DAL, were calculated based on the FFQ. RESULTS The study analyzed 345 participants, comprising 174 (50.4%) MS patients and 171 (49.6%) healthy individuals. The mean age of the participants was 32.45 ± 8.66 years. The DPI score was significantly lower among MS patients, while the NEAP and PRAL scores were significantly higher among MS patients compared to the healthy group. There was no relationship between NEAP (OR 1.001; 95% CI 0.959-1.044; P = 0.974) and PRAL (OR 1.019; 95% CI 0.979-1.061; P = 0.356) and MS incidence. CONCLUSIONS The study found higher smoking and obesity rates in MS patients, with a reduced DPI score and increased DAL. Further studies are needed before recommending plant-based foods and dietary acid-base balance evaluation as therapeutic approach.
Collapse
Affiliation(s)
- Alireza Hatami
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran
| | - Maryam Ahmadi-Khorram
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran
| | - Fatemeh Keykhaei
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran
| | - Mohtaram Hashemi
- Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
| | - Reihane Javid
- Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
| | - Mehrara Hashempour
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran
| | | | - Mohsen Nematy
- Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 91779-48564, Iran.
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
| |
Collapse
|
4
|
Mincic AM, Antal M, Filip L, Miere D. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review. Clin Nutr 2024; 43:1832-1849. [PMID: 38878554 DOI: 10.1016/j.clnu.2024.05.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Revised: 05/24/2024] [Accepted: 05/24/2024] [Indexed: 06/25/2024]
Abstract
BACKGROUND AND AIMS Microbiota plays an essential role in maintaining body health, through positive influences on metabolic, defensive, and trophic processes and on intercellular communication. Imbalance in intestinal flora, with the proliferation of harmful bacterial species (dysbiosis) is consistently reported in chronic illnesses, including neurodegenerative diseases (ND). Correcting dysbiosis can have a beneficial impact on the symptoms and evolution of ND. This review examines the effects of microbiota modulation through administration of probiotics, prebiotics, symbiotics, or prebiotics' metabolites (postbiotics) in patients with ND like multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). METHODS PubMed, Web of Science, Medline databases and ClinicalTrials.gov registry searches were performed using pre-/pro-/postbiotics and ND-related terms. Further references were obtained by checking relevant articles. RESULTS Although few compared to animal studies, the human studies generally show positive effects on disease-specific symptoms, overall health, metabolic parameters, on oxidative stress and immunological markers. Therapy with probiotics in various forms (mixtures of bacterial strains, fecal microbiota transplant, diets rich in fermented foods) exert favorable effects on patients' mental health, cognition, and quality of life, targeting pathogenetic ND mechanisms and inducing reparatory mechanisms at the cellular level. More encouraging results have been observed in prebiotic/postbiotic therapy in some ND. CONCLUSIONS The effects of probiotic-related interventions depend on the patients' ND stage and pre-existing allopathic medication. Further studies on larger cohorts and long term comprehensive neuropsychiatric, metabolic, biochemical testing, and neuroimaging monitoring are necessary to optimize therapeutic protocols in ND.
Collapse
Affiliation(s)
- Adina M Mincic
- Center for Systems Neuroscience, University of Oradea, Oradea, Romania; Department of Preclinical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania; Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.
| | - Miklos Antal
- Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Lorena Filip
- Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
| | - Doina Miere
- Faculty of Pharmacy, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania
| |
Collapse
|
5
|
Dai L, Lin X, Wang S, Gao Y, He F. The Mediterranean-dietary approaches to stop hypertension diet intervention for neurodegenerative delay (MIND) diet: a bibliometric analysis. Front Nutr 2024; 11:1348808. [PMID: 38946791 PMCID: PMC11211596 DOI: 10.3389/fnut.2024.1348808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 05/24/2024] [Indexed: 07/02/2024] Open
Abstract
The MIND diet is a healthy dietary pattern that has some benefits for many health outcomes. Our study aims to conduct a bibliometric analysis of the MIND diet, identifying leading edges and hotspots to provide a reference for future research. The research on the MIND diet was gathered from the Web of Science Core Collection (WOSCC) database. For bibliometric analysis, VOSviewer 1.6.16 and the WOSCC Online Analysis Platform were utilized. In total, this comprehensive investigation encompassed 171 documents in the field of the MIND diet. The publications are globally distributed, with contributions from 953 authors across 362 institutions in 37 countries/regions, and published in 94 journals. The United States leads with 72 publications, and Iran and the People's Republic of China also show notable engagement with 28 and 19 publications, respectively. Rush University stands out with 21 publications, followed by Harvard University and Tehran University of Medical Sciences, demonstrating their substantial contributions to this field. Martha Clare Morris is a key figure with 10 publications, alongside Klodian Dhana and Puja Agarwal, each contributing 9 publications, highlighting their influence in the MIND diet research. The journal "Nutrients" is a major publication venue with 20 related articles, followed by "Frontiers in Nutrition" and "Journal of Nutrition Health Aging," reflecting their crucial roles in advancing knowledge about the MIND diet. The first high-cited publication was published in Alzheimers & Dementia and conducted by Martha Clare Morris, which focuses on the MIND diet's relationship with Alzheimer's disease prevention and cognitive decline and emphasizes the diet's neuroprotective potential, highlighting how even moderate adherence can substantially reduce Alzheimer's risk and slow cognitive decline. In conclusion, this is the first comprehensive bibliometric study that quantitatively and qualitatively analyzed the publications in the field of the MIND diet. The MIND diet may be a promising dietary pattern for dementia. However, the current evidence is restricted and highlights the urgency and necessity of further research to investigate the efficacy of this diet for cognitive function. In addition, the MIND diet may have some benefits for other health outcomes, including CVDs, cancer, and diabetes. The number of studies in the field of the MIND diet is limited. More studies are needed, and will give us more knowledge about the MIND diet to improve human health, especially for dementia.
Collapse
Affiliation(s)
| | | | - Shuai Wang
- Hangzhou First Hospital, Hangzhou, China
| | - Yue Gao
- Hangzhou First Hospital, Hangzhou, China
| | - Fei He
- Taizhou Municipal Hospital, Taizhou, China
| |
Collapse
|
6
|
Sartorio A, Dal Pont C, Romano S. Standard and New Echocardio Techniques, Such as Global Longitudinal Strain, to Monitor the Impact of Diets on Cardiovascular Diseases and Heart Function. Nutrients 2024; 16:1471. [PMID: 38794710 PMCID: PMC11124322 DOI: 10.3390/nu16101471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 04/29/2024] [Accepted: 05/10/2024] [Indexed: 05/26/2024] Open
Abstract
"The Seven Countries Study", published in 1984, was the first study to find a correlation between diet and mortality related to cardiovascular diseases (CVDs). Since then, many investigations have addressed the relationship between type of diet, or specific nutrients, and CVDs. Based on these findings, some traditional dietary models, such as the Mediterranean or Nordic diet, are recommended to prevent CVDs. Meanwhile, new diets have been proposed for optimal nutrition therapy, for example, the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean-DASH Intervention Diet for Neurodegenerative Delay (MIND). The main outcomes evaluated after implementing these dietary models are as follows: CVD-related death; the development of specific CVDs, such as myocardial infarction and hypertension; or biochemical parameters related to CVDs, i.e., non-HDL cholesterol, C-reactive protein (CPR) and homocysteine. However, the early impact of diet on heart functionality is less evaluated. Recently, the echographic measurement of left ventricle (LV) deformation by global longitudinal strain (GLS) has been introduced as a novel marker of clinical and subclinical cardiac dysfunction. This technology allows a subclinical evaluation of heart functionality since, differently from the traditional evaluation of left ventricle ejection fraction (LVEF), it is capable of detecting early myocardial dysfunction. In this review, we analyzed the available studies that correlate dietetic regimens to cardiovascular diseases, focusing on the relevance of LV strain to detect subclinical myocardial alteration related to diet. Evidence is presented that DASH and MIND can have a positive impact on heart functionality and that myocardial strain is useful for early detection of diet-related changes in cardiac function.
Collapse
Affiliation(s)
| | | | - Simone Romano
- Division of Internal Medicine C, Department of Internal Medicine, University of Verona, 37134 Verona, Italy; (A.S.); (C.D.P.)
| |
Collapse
|
7
|
Shea MK, Strath L, Kim M, Ðoàn LN, Booth SL, Brinkley TE, Kritchevsky SB. Perspective: Promoting Healthy Aging through Nutrition: A Research Centers Collaborative Network Workshop Report. Adv Nutr 2024; 15:100199. [PMID: 38432592 PMCID: PMC10965474 DOI: 10.1016/j.advnut.2024.100199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Revised: 02/21/2024] [Accepted: 02/23/2024] [Indexed: 03/05/2024] Open
Abstract
Within 20 y, the number of adults in the United States over the age of 65 y is expected to more than double and the number over age 85 y is expected to more than triple. The risk for most chronic diseases and disabilities increases with age, so this demographic shift carries significant implications for the individual, health care providers, and population health. Strategies that delay or prevent the onset of age-related diseases are becoming increasingly important. Although considerable progress has been made in understanding the contribution of nutrition to healthy aging, it has become increasingly apparent that much remains to be learned, especially because the aging process is highly variable. Most federal nutrition programs and nutrition research studies define all adults over age 65 y as "older" and do not account for physiological and metabolic changes that occur throughout older adulthood that influence nutritional needs. Moreover, the older adult population is becoming more racially and ethnically diverse, so cultural preferences and other social determinants of health need to be considered. The Research Centers Collaborative Network sponsored a 1.5-d multidisciplinary workshop that included sessions on dietary patterns in health and disease, timing and targeting interventions, and health disparities and the social context of diet and food choice. The agenda and presentations can be found at https://www.rccn-aging.org/nutrition-2023-rccn-workshop. Here we summarize the workshop's themes and discussions and highlight research gaps that if filled will considerably advance our understanding of the role of nutrition in healthy aging.
Collapse
Affiliation(s)
- M Kyla Shea
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States.
| | - Larissa Strath
- College of Medicine, Department of Health Outcomes and Biomedical Informatics, the University of Florida, Gainesville, FL, United States; Clinical and Translational Science Institute, Pain Research and Intervention Center of Excellence, the University of Florida, Gainesville, FL, United States
| | - Minjee Kim
- Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Institute of Public Health Medicine, Center for Applied Health Research on Aging, Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Center for Circadian and Sleep Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
| | - Lan N Ðoàn
- Department for Population Health, Section for Health Equity, New York University Grossman School of Medicine, New York, NY, United States
| | - Sarah L Booth
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States
| | - Tina E Brinkley
- Department of Gerontology and Geriatric Medicine, Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| | - Stephen B Kritchevsky
- Department of Gerontology and Geriatric Medicine, Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, United States
| |
Collapse
|
8
|
Derdiger S, Friedeborn S, Tangney CC. Cognitive performance in relation to MIND and MEPA III dietary pattern accordance of NHANES participants. J Hum Nutr Diet 2024; 37:18-30. [PMID: 37656632 DOI: 10.1111/jhn.13223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2023] [Revised: 06/30/2023] [Accepted: 07/24/2023] [Indexed: 09/03/2023]
Abstract
BACKGROUND There is growing evidence that Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) and Mediterranean-like diets are associated with better cognitive performance. METHODS In this cross-sectional sample from two NHANES cycles (2011-2014), scores for the MIND dietary pattern (maximum score = 14) and for the Mediterranean Eating Pattern for Americans (MEPA) III (maximum score = 22) were calculated based on the reported foods consumed on two nonconsecutive 24-h dietary recalls. Only adults with two completed recalls and cognitive testing were studied (n = 2598). Cognitive assessments included the word learning and recall components from the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Animal Fluency test (AFT) and Digit Symbol Substitution Test. RESULTS The ages of participants were (mean ± SD) 69.2 ± 0.3 years, with almost equal proportions of men and women. MIND score was 5.0 ± 0.0, and MEPA III score was 8.6 ± 2.1. Positive associations between continuous MIND scores and education-dependent standardised cognitive scores for each test and global cognition were observed, unadjusted or adjusted for covariates; no such associations were observed for MEPA III. Compared to adults in the lowest MIND tertile, those in the highest were less likely to exhibit low cognitive performance on the AFT [0.45 (0.29-0.69)], CERAD Delayed Recall [0.52 (0.32-0.83)] and global cognition [0.50 (0.27-0.94)]. Similar observations were noted with MEPA III with AFT [0.58 (0.43-0.79)] and CERAD Delayed Recall [0.66 (0.46-0.94)]. CONCLUSIONS Older Americans were generally non-accordant to MIND and MEPA III patterns. However, those who reported greater MIND or MEPA III diet accordance exhibited better cognitive performance.
Collapse
Affiliation(s)
- Samara Derdiger
- Department of Clinical Nutrition and of Family and Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA
| | - Sophia Friedeborn
- Department of Food and Nutrition Services, Saint Francis Hospital, Wilmington, Delaware, USA
| | - Christy C Tangney
- Department of Clinical Nutrition and of Family and Preventive Medicine, Rush University Medical Center, Chicago, Illinois, USA
| |
Collapse
|
9
|
Chen H, Dunk MM, Wang B, Zhao M, Shen J, Zong G, Pan Y, Tong L, Xu W, Yuan C. Associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay diet with brain structural markers and their changes. Alzheimers Dement 2024; 20:1190-1200. [PMID: 37932860 PMCID: PMC10917040 DOI: 10.1002/alz.13521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 09/19/2023] [Accepted: 10/02/2023] [Indexed: 11/08/2023]
Abstract
INTRODUCTION The associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet with brain structural changes are unclear. METHODS Among 26,466 UK Biobank participants, a 15-point MIND score was calculated from 24-hour diet recalls from 2009 to 2012. We assessed its associations with 17 magnetic-resonance-derived brain volumetric markers and their longitudinal changes and explored whether genetic factors modify the associations. RESULTS Higher MIND adherence was associated with larger volumes of thalamus, putamen, pallidum, hippocampus, and accumbens (beta per 3-unit increment ranging from 0.024 to 0.033) and lower white matter hyperintensities (P-trends < 0.05), regardless of genetic predispositions of Alzheimer's disease. MIND score was not associated with their longitudinal changes (P > 0.05) over a median of 2.2 years among participants with repeated imaging assessments (N = 2963), but was associated with slower atrophy in putamen (beta: 0.026, P-trend = 0.044) and pallidum (beta: 0.030, P-trend = 0.033) among APOE ε4 non-carriers (N = 654). DISCUSSION The MIND diet showed beneficial associations with certain brain imaging markers, and its associations with long-term brain structural changes warrants future investigation. HIGHLIGHTS Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet was significantly associated with higher volumes and larger gray matter volumes in certain brain regions in UK adults, and the associations were not modified by genetic factors. No significant associations were observed between MIND diet and longitudinal changes in the investigated brain structural markers over a median of 2.2 years. Higher MIND score was significantly associated with slower atrophy in the putamen and pallidum among APOE ε4 non-carriers.
Collapse
Affiliation(s)
- Hui Chen
- School of Public Healththe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Michelle M. Dunk
- Aging Research CenterDepartment of NeurobiologyCare Sciences and SocietyKarolinska Institute and Stockholm UniversityStockholmSweden
| | - Binghan Wang
- School of Public Healththe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Mengjia Zhao
- School of Public Healththe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Jie Shen
- School of Public Healththe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Geng Zong
- CAS Key Laboratory of NutritionMetabolism and Food SafetyShanghai Institute of Nutrition and HealthUniversity of Chinese Academy of SciencesChinese Academy of SciencesShanghaiChina
| | - Yuesong Pan
- Department of NeurologyBeijing Tiantan HospitalCapital Medical UniversityBeijingChina
| | - Lusha Tong
- Department of Neurologythe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Weili Xu
- Aging Research CenterDepartment of NeurobiologyCare Sciences and SocietyKarolinska Institute and Stockholm UniversityStockholmSweden
| | - Changzheng Yuan
- School of Public Healththe Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
- Department of NutritionHarvard T. H. Chan School of Public HealthBostonMassachusettsUSA
| |
Collapse
|
10
|
Yuan L, Li Y, Chen M, Xue L, Wang J, Ding Y, Gu Q, Zhang J, Zhao H, Xie X, Wu Q. Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives. Appl Microbiol Biotechnol 2024; 108:156. [PMID: 38244075 PMCID: PMC10799778 DOI: 10.1007/s00253-024-13007-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Revised: 12/21/2023] [Accepted: 01/08/2024] [Indexed: 01/22/2024]
Abstract
Cardiometabolic disease (CMD) encompasses a range of diseases such as hypertension, atherosclerosis, heart failure, obesity, and type 2 diabetes. Recent findings about CMD's interaction with gut microbiota have broadened our understanding of how diet and nutrition drive microbes to influence CMD. However, the translation of basic research into the clinic has not been smooth, and dietary nutrition and probiotic supplementation have yet to show significant evidence of the therapeutic benefits of CMD. In addition, the published reviews do not suggest the core microbiota or metabolite classes that influence CMD, and systematically elucidate the causal relationship between host disease phenotypes-microbiome. The aim of this review is to highlight the complex interaction of the gut microbiota and their metabolites with CMD progression and to further centralize and conceptualize the mechanisms of action between microbial and host disease phenotypes. We also discuss the potential of targeting modulations of gut microbes and metabolites as new targets for prevention and treatment of CMD, including the use of emerging technologies such as fecal microbiota transplantation and nanomedicine. KEY POINTS: • To highlight the complex interaction of the gut microbiota and their metabolites with CMD progression and to further centralize and conceptualize the mechanisms of action between microbial and host disease phenotypes. • We also discuss the potential of targeting modulations of gut microbes and metabolites as new targets for prevention and treatment of CMD, including the use of emerging technologies such as FMT and nanomedicine. • Our study provides insight into identification-specific microbiomes and metabolites involved in CMD, and microbial-host changes and physiological factors as disease phenotypes develop, which will help to map the microbiome individually and capture pathogenic mechanisms as a whole.
Collapse
Affiliation(s)
- Lin Yuan
- School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Ying Li
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Moutong Chen
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Liang Xue
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Juan Wang
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Yu Ding
- Department of Food Science and Engineering, Institute of Food Safety and Nutrition, College of Science & Engineering, Jinan University, Guangzhou, 510632, China
| | - Qihui Gu
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Jumei Zhang
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Hui Zhao
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China
| | - Xinqiang Xie
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China.
| | - Qingping Wu
- Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Key Laboratory of Agricultural Microbiomics and Precision Application, Ministry of Agriculture and Rural Affairs, Guangdong Academy of Sciences, Guangzhou, 510070, China.
| |
Collapse
|
11
|
Halloway S, Wagner M, Tangney C, Lange‐Maia BS, Bennett DA, Arvanitakis Z, Schoeny ME. Profiles of lifestyle health behaviors and cognitive decline in older adults. Alzheimers Dement 2024; 20:472-482. [PMID: 37676928 PMCID: PMC10840675 DOI: 10.1002/alz.13459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 07/24/2023] [Accepted: 08/13/2023] [Indexed: 09/09/2023]
Abstract
INTRODUCTION We aimed to identify profiles of modifiable, late-life lifestyle health behaviors related to subsequent maintenance of cognition and explore sociodemographics and health characteristics as effect modifiers. METHODS Analyses used data from 715 older adults without baseline dementia from the Rush Memory and Aging Project and with lifestyle health behaviors (physical activity, cognitive activity, healthy diet, social activity) at baseline and ≥ 2 annual assessments of cognition. We used latent profile analysis to group participants based on behavior patterns and assessed change in cognition by group. RESULTS Three latent profiles were identified: high (n = 183), moderate (n = 441), and low (n = 91) engagement in health behaviors. Compared to high engagement, the moderate (mean difference [MD] = -0.02, 95% CI = [-0.03;-0.0002], p = 0.048) and low (MD = -0.06, 95% CI = [-0.08;-0.03], p < 0.0001) groups had faster annual rates of decline in global cognition, with no significant effects modifiers (vascular risk factors, apolipoprotein E [APOE] ε4, motor function). DISCUSSION Avoiding low levels of lifestyle health behaviors may help maintain cognition. HIGHLIGHTS Latent profile analysis (LPA) captures lifestyle health behaviors associated with cognitive function. Such behavior include physical activity, cognitive activity, healthy diet, social activity. We used LPA to examine associations of behaviors and cognitive function over time. Older adults with low lifestyle health behaviors showed more rapid decline. To a lesser degree, so did those with moderate lifestyle health behaviors. Vascular conditions and risks, APOEε4, or motor function did not modify the effect.
Collapse
Affiliation(s)
- Shannon Halloway
- Department of Biobehavioral Nursing ScienceCollege of NursingUniversity of Illinois ChicagoChicagoIllinoisUSA
| | - Maude Wagner
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- University of BordeauxBordeauxFrance
| | - Christy Tangney
- Department of Clinical NutritionRush College of Health SciencesChicagoIllinoisUSA
- Department of Family and Preventive MedicineRush Medical CollegeChicagoIllinoisUSA
| | - Brittney S. Lange‐Maia
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Family and Preventive MedicineRush Medical CollegeChicagoIllinoisUSA
| | - David A. Bennett
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
| | - Zoe Arvanitakis
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
| | - Michael E. Schoeny
- Department of CommunitySystemsand Mental Health NursingRush University College of NursingChicagoIllinoisUSA
| |
Collapse
|
12
|
Seo Y, Gang G, Kim HK, Kim Y, Kang S, Kim H, Lee SG, Go GW. Effect of MIND diet on cognitive function in elderly: a narrative review with emphasis on bioactive food ingredients. Food Sci Biotechnol 2024; 33:297-306. [PMID: 38222909 PMCID: PMC10786772 DOI: 10.1007/s10068-023-01465-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Revised: 10/03/2023] [Accepted: 10/10/2023] [Indexed: 01/16/2024] Open
Abstract
As the world becomes a super-aged society, cognitive decline is public health problems that are increasing rapidly. A healthy diet has great potential for maintaining cognitive health. A diet that could delay the onset of neurodegenerative diseases has been developed: the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, a hybrid form of the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet. In this review, the effects of the MIND diet on improving cognitive function, including memory, are summarized. In most studies, the higher the adherence to the MIND diet, the higher the cognitive function evaluation score, and the lower the incidence of dementia. This is because of the anti-inflammatory and antioxidant effects of the major nutritional components of the MIND diet: folate, carotenoids, polyphenols, and polyunsaturated fatty acids. Adherence to the MIND diet, containing various bioactive food ingredients, is related to cognitive improvement in the elderly population.
Collapse
Affiliation(s)
- Yuhyun Seo
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| | - Gyoungok Gang
- Department of Food Science and Nutrition, Pukyong National University, Busan, 48513 Republic of Korea
| | - Hyun Kyung Kim
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| | - Yejin Kim
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| | - Sumin Kang
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| | - Hayoon Kim
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| | - Sang Gill Lee
- Department of Food Science and Nutrition, Pukyong National University, Busan, 48513 Republic of Korea
| | - Gwang-woong Go
- Department of Food and Nutrition, Hanyang University, Seoul, 04763 Republic of Korea
| |
Collapse
|
13
|
Besser LM, Chrisphonte S, Kleiman MJ, O’Shea D, Rosenfeld A, Tolea M, Galvin JE. The Healthy Brain Initiative (HBI): A prospective cohort study protocol. PLoS One 2023; 18:e0293634. [PMID: 37889891 PMCID: PMC10610524 DOI: 10.1371/journal.pone.0293634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Accepted: 10/16/2023] [Indexed: 10/29/2023] Open
Abstract
BACKGROUND The Health Brain Initiative (HBI), established by University of Miami's Comprehensive Center for Brain Health (CCBH), follows racially/ethnically diverse older adults without dementia living in South Florida. With dementia prevention and brain health promotion as an overarching goal, HBI will advance scientific knowledge by developing novel assessments and non-invasive biomarkers of Alzheimer's disease and related dementias (ADRD), examining additive effects of sociodemographic, lifestyle, neurological and biobehavioral measures, and employing innovative, methodologically advanced modeling methods to characterize ADRD risk and resilience factors and transition of brain aging. METHODS HBI is a longitudinal, observational cohort study that will follow 500 deeply-phenotyped participants annually to collect, analyze, and store clinical, cognitive, behavioral, functional, genetic, and neuroimaging data and biospecimens. Participants are ≥50 years old; have no, subjective, or mild cognitive impairment; have a study partner; and are eligible to undergo magnetic resonance imaging (MRI). Recruitment is community-based including advertisements, word-of-mouth, community events, and physician referrals. At baseline, following informed consent, participants complete detailed web-based surveys (e.g., demographics, health history, risk and resilience factors), followed by two half-day visits which include neurological exams, cognitive and functional assessments, an overnight sleep study, and biospecimen collection. Structural and functional MRI is completed by all participants and a subset also consent to amyloid PET imaging. Annual follow-up visits repeat the same data and biospecimen collection as baseline, except that MRIs are conducted every other year after baseline. ETHICS AND EXPECTED IMPACT HBI has been approved by the University of Miami Miller School of Medicine Institutional Review Board. Participants provide informed consent at baseline and are re-consented as needed with protocol changes. Data collected by HBI will lead to breakthroughs in developing new diagnostics and therapeutics, creating comprehensive diagnostic evaluations, and providing the evidence base for precision medicine approaches to dementia prevention with individualized treatment plans.
Collapse
Affiliation(s)
- Lilah M. Besser
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - Stephanie Chrisphonte
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - Michael J. Kleiman
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - Deirdre O’Shea
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - Amie Rosenfeld
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - Magdalena Tolea
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| | - James E. Galvin
- Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, United States of America
| |
Collapse
|
14
|
Wu X, Zhang T, Tu Y, Deng X, Sigen A, Li Y, Jing X, Wei L, Huang N, Cheng Y, Deng L, Jia S, Li J, Jiang N, Dong B. Multidomain interventions for non-pharmacological enhancement (MINE) program in Chinese older adults with mild cognitive impairment: a multicenter randomized controlled trial protocol. BMC Neurol 2023; 23:341. [PMID: 37759178 PMCID: PMC10537159 DOI: 10.1186/s12883-023-03390-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 09/13/2023] [Indexed: 09/29/2023] Open
Abstract
BACKGROUND Dementia is characterized by progressive neurodegeneration and therefore early intervention could have the best chance of preserving brain health. There are significant differences in health awareness, living customs, and daily behaviors among Chinese older adults compared to Europeans and Americans. Because the synergistic benefits of multidomain non-pharmacological interventions are consistent with the multifactorial pathogenicity of MCI, such interventions are more appealing, easier to adhere to, and more relevant to daily life than single-mode interventions. One of the aims of this study is to verify the effect of multidomain intervention strategies for MCI patients based on Chinese population characteristics, and the other is to establish a biobank and image database to investigate the pathogenesis and pathways of cognitive impairment. METHODS Our study was designed as a national multicenter, community-based randomized controlled trial (RCT). Twelve medical institutions in ten Chinese cities will participate in our study from 2020 to 2024, and 1080 community residents aged 50 and above will be enrolled as participants. Each sub-center will be responsible for 90 participants (30 people per community) across three communities (non-contact control group, health education group, and multidomain intervention group). The community will be the basic unit of the present study, and all participants in each community will receive the same intervention/control measure. Three working groups are set up in each sub-center to manage the three communities independently to minimize interference at the implementation level between the groups. The multidomain intervention group will receive integrated interventions including exercise, nutrition, sleep, health education and mindfulness meditation. All data generated by the research will be analyzed and processed by statistical software (such as SPSS 21.0, Python 3.0, etc.), and part of the research data will be displayed in the form of graphs and tables. DISCUSSION In order to achieve a high-quality community intervention study, it is crucial to have a well-designed experimental protocol that follows rigorous scientific methodology. In addition, effective management of quality control measures and monitoring compliance throughout the study process are essential components. This study provides a detailed discussion of stakeholder compliance, research quality control, potential harm and mitigation, auditing, and future plans in order to better address research issues. TRIAL REGISTRATION ChiCTR2000035012 (July 27, 2020).
Collapse
Affiliation(s)
- Xiaochu Wu
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Tianyao Zhang
- The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
| | - Yanhao Tu
- Strength and Conditioning Center, Chengdu Sport University, Chengdu, China
| | - Xueling Deng
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - A Sigen
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Yuxiao Li
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Xiaofan Jing
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Lixuan Wei
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Ning Huang
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Ying Cheng
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Linghui Deng
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Shuli Jia
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Jun Li
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China
| | - Ning Jiang
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
| | - Birong Dong
- National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
| |
Collapse
|
15
|
Besser LM, Chrisphonte S, Kleiman MJ, O'Shea D, Rosenfeld A, Tolea M, Galvin JE. The Healthy Brain Initiative (HBI): A prospective cohort study protocol. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.09.21.23295908. [PMID: 37808766 PMCID: PMC10557773 DOI: 10.1101/2023.09.21.23295908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/10/2023]
Abstract
Background The Health Brain Initiative (HBI), established by University of Miami's Comprehensive Center for Brain Health (CCBH), follows racially/ethnically diverse older adults without dementia living in South Florida. With dementia prevention and brain health promotion as an overarching goal, HBI will advance scientific knowledge by developing novel assessments and non-invasive biomarkers of Alzheimer's disease and related dementias (ADRD), examining additive effects of sociodemographic, lifestyle, neurological and biobehavioral measures, and employing innovative, methodologically advanced modeling methods to characterize ADRD risk and resilience factors and transition of brain aging. Methods HBI is a longitudinal, observational cohort study that will follow 500 deeply-phenotyped participants annually to collect, analyze, and store clinical, cognitive, behavioral, functional, genetic, and neuroimaging data and biospecimens. Participants are ≥50 years old; have no, subjective, or mild cognitive impairment; have a study partner; and are eligible to undergo magnetic resonance imaging (MRI). Recruitment is community-based including advertisements, word-of-mouth, community events, and physician referrals. At baseline, following informed consent, participants complete detailed web-based surveys (e.g., demographics, health history, risk and resilience factors), followed by two half-day visits which include neurological exams, cognitive and functional assessments, an overnight sleep study, and biospecimen collection. Structural and functional MRI is completed by all participants and a subset also consent to amyloid PET imaging. Annual follow-up visits repeat the same data and biospecimen collection as baseline, except that MRIs are conducted every other year after baseline. Ethics and expected impact HBI has been approved by the University of Miami Miller School of Medicine Institutional Review Board. Participants provide informed consent at baseline and are re-consented as needed with protocol changes. Data collected by HBI will lead to breakthroughs in developing new diagnostics and therapeutics, create comprehensive diagnostic evaluations, and provide the evidence base for precision medicine approaches to dementia prevention with individualized treatment plans.
Collapse
|
16
|
Dening KH. Modifiable and non-modifiable risk factors for dementia: what primary care nurses need to know. Br J Community Nurs 2023; 28:430-438. [PMID: 37638750 DOI: 10.12968/bjcn.2023.28.9.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/29/2023]
Abstract
Dementia is an umbrella term used to describe a group of symptoms characterised by behavioural changes, loss of cognitive and social functioning brought about by progressive neurological disorders. There are estimated to be 944 000 people living with dementia in the UK and it is indicated that this will increase to 2 million by 2051. We are learning more about the risk factors for developing dementia over the life course. This paper discusses the modifiable and non-modifiable risk factors for dementia and considers health promotion and health education activities that can be used in a primary care setting.
Collapse
Affiliation(s)
- Karen Harrison Dening
- Head of Research and Publications, Dementia UK; Honorary Professor of Dementia Research, De Montfort University Gateway House, Leicester, UK
| |
Collapse
|
17
|
Bays HE. Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review. OBESITY PILLARS (ONLINE) 2023; 7:100076. [PMID: 37990681 PMCID: PMC10661899 DOI: 10.1016/j.obpill.2023.100076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 06/11/2023] [Accepted: 06/12/2023] [Indexed: 11/23/2023]
Abstract
Background A common adiposopathic complication of obesity is type 2 diabetes mellitus. Healthful weight reduction in patients with obesity can improve glucose metabolism and potentially promote remission of type 2 diabetes mellitus. However, weight-reduction in patients with increased adiposity is impaired among patients with type 2 diabetes mellitus compared to patients without diabetes mellitus. Methods Data for this review were derived from PubMed and applicable websites. Results Among patients with increased body fat, the mechanisms underlying impaired weight reduction for those with type 2 diabetes mellitus are multifactorial, and include energy conservation (i.e., improved glucose control and reduced glucosuria), hyperinsulinemia (commonly found in many patients with type 2 diabetes mellitus), potential use of obesogenic anti-diabetes medications, and contributions from multiple body systems. Other factors include increased age, sex, genetic/epigenetic predisposition, and obesogenic environments. Conclusions Even though type 2 diabetes mellitus impairs weight reduction among patients with increased adiposity, clinically meaningful weight reduction improves glucose metabolism and can sometimes promote diabetes remission. An illustrative approach to mitigate impaired weight reduction due to type 2 diabetes mellitus is choosing anti-diabetes medications that increase insulin sensitivity and promote weight loss and deprioritize use of anti-diabetes medications that increase insulin exposure and promote weight gain.
Collapse
Affiliation(s)
- Harold Edward Bays
- Diplomate of American Board of Medicine, Medical Director / President, Louisville Metabolic and Atherosclerosis Research Center, Clinical Associate Professor, University of Louisville School of Medicine, 3288 Illinois Avenue, Louisville, KY, 40213, USA
| |
Collapse
|
18
|
Melo van Lent D, Mesa HG, Short MI, Gonzales MM, Aparicio HJ, Salinas J, Yuan C, Jacques PF, Beiser A, Seshadri S, Jacob ME, Himali JJ. Association between dietary inflammatory index score and incident dementia: results from the Framingham heart Study offspring cohort. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.08.21.23294374. [PMID: 37662354 PMCID: PMC10473791 DOI: 10.1101/2023.08.21.23294374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/05/2023]
Abstract
Background The Dietary Inflammatory Index (DII), has been specifically designed to capture the inflammatory content of diet and has shown association with neurodegenerative disease related outcomes. But literature is limited on the role of diet-driven inflammation measured by the DII on incident all-cause dementia and Alzheimer's disease dementia (AD). Objective We evaluated whether higher DII scores were associated with increased incidence of all-cause dementia and AD over 22.3 years of follow-up in the community-based Framingham Heart Study (FHS) Offspring cohort. Design Setting and Participants Observational longitudinal study in the FHS Offspring cohort. Dementia surveillance for present study: until 2020. Data were analyzed from December 2020 to June 2022. Participants completed a validated 126-item food frequency questionnaires (FFQ), administered at FHS examination cycle 7 (1998-2001) and examination cycle 5 (1991-1995), and/or 6 (1995-1998). Individuals aged <60 years, with prevalent dementia, no dementia follow-up, other relevant neurological diseases, and/or no FFQ data were excluded. Exposure A DII score (based on the published method by Shivappa et al. 2014) was created based on previous studies linking individual dietary factors to six inflammatory markers (i.e. C-reactive protein, interleukin (IL)-1β, IL-4, IL-6, IL-10, and tumor necrosis factor-alpha), consisting of 36 components. A cumulative DII score was calculated by averaging across a maximum of three FFQs. Main outcomes and measures Incident all-cause dementia and AD. Results We included 1487 participants (mean±SD, age in years 69 ± 6; 53·2% women; 31·6% college graduates]). 246 participants developed all-cause dementia (including AD n=187) over a median follow up time of 13·1 years. Higher DII scores were associated with an increased incidence of all-cause dementia and AD following adjustment for age and sex (Hazard ratio (HR) 1·16, 95% confidence interval (CI) 1·07 to 1·25, p<.001; HR 1·16, 95% CI 1·06 to 1·26, p=.001). The relationships remained after additional adjustment for demographic, lifestyle, and clinical covariates (HR 1·21, 95% CI 1·10 to 1·33, p<0.001; HR1·20, 95% CI1·07 to 1·35, p=.001). Conclusion and relevance Higher DII scores were associated with a higher risk of incident all-cause dementia and AD. Although these promising findings need to be replicated and further validated, our results suggest that diets which correlate with low DII scores may prevent late-life dementia.
Collapse
|
19
|
Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, Hollings CS, Bishop L, Laranjo N, Stubbs BJ, Reilly X, Agarwal P, Zhang S, Grodstein F, Tangney CC, Holland TM, Aggarwal NT, Arfanakis K, Morris MC, Sacks FM. Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. N Engl J Med 2023; 389:602-611. [PMID: 37466280 PMCID: PMC10513737 DOI: 10.1056/nejmoa2302368] [Citation(s) in RCA: 60] [Impact Index Per Article: 60.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/20/2023]
Abstract
BACKGROUND Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean-DASH Intervention for Neurodegenerative Delay, known as the MIND diet, is a hybrid of the Mediterranean diet and the DASH (Dietary Approaches to Stop Hypertension) diet, with modifications to include foods that have been putatively associated with a decreased risk of dementia. METHODS We performed a two-site, randomized, controlled trial involving older adults without cognitive impairment but with a family history of dementia, a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 25, and a suboptimal diet, as determined by means of a 14-item questionnaire, to test the cognitive effects of the MIND diet with mild caloric restriction as compared with a control diet with mild caloric restriction. We assigned the participants in a 1:1 ratio to follow the intervention or the control diet for 3 years. All the participants received counseling regarding adherence to their assigned diet plus support to promote weight loss. The primary end point was the change from baseline in a global cognition score and four cognitive domain scores, all of which were derived from a 12-test battery. The raw scores from each test were converted to z scores, which were averaged across all tests to create the global cognition score and across component tests to create the four domain scores; higher scores indicate better cognitive performance. The secondary outcome was the change from baseline in magnetic resonance imaging (MRI)-derived measures of brain characteristics in a nonrandom sample of participants. RESULTS A total of 1929 persons underwent screening, and 604 were enrolled; 301 were assigned to the MIND-diet group and 303 to the control-diet group. The trial was completed by 93.4% of the participants. From baseline to year 3, improvements in global cognition scores were observed in both groups, with increases of 0.205 standardized units in the MIND-diet group and 0.170 standardized units in the control-diet group (mean difference, 0.035 standardized units; 95% confidence interval, -0.022 to 0.092; P = 0.23). Changes in white-matter hyperintensities, hippocampal volumes, and total gray- and white-matter volumes on MRI were similar in the two groups. CONCLUSIONS Among cognitively unimpaired participants with a family history of dementia, changes in cognition and brain MRI outcomes from baseline to year 3 did not differ significantly between those who followed the MIND diet and those who followed the control diet with mild caloric restriction. (Funded by the National Institute on Aging; ClinicalTrials.gov number, NCT02817074.).
Collapse
Affiliation(s)
- Lisa L Barnes
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Klodian Dhana
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Xiaoran Liu
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Vincent J Carey
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Jennifer Ventrelle
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Kathleen Johnson
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Chiquia S Hollings
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Louise Bishop
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Nancy Laranjo
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Benjamin J Stubbs
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Xavier Reilly
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Puja Agarwal
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Shengwei Zhang
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Francine Grodstein
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Christy C Tangney
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Thomas M Holland
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Neelum T Aggarwal
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Konstantinos Arfanakis
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Martha Clare Morris
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| | - Frank M Sacks
- From Rush Alzheimer's Disease Center (L.L.B., P.A., S.Z., F.G., N.T.A., K.A.), the Department of Neurology (L.L.B., N.T.A.), Rush Institute for Healthy Aging (K.D., X.L., C.S.H., T.M.H.), and the Departments of Internal Medicine (K.D., X.L., C.S.H., P.A., F.G., T.M.H., M.C.M.), Clinical Nutrition (J.V., P.A., C.C.T.), Preventive Medicine (J.V., C.C.T.), and Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center, and the Department of Biomedical Engineering, Illinois Institute of Technology (K.A.) - all in Chicago; and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital (V.J.C., N.L., B.J.S., X.R.), Harvard Medical School (V.J.C., N.L., B.J.S., X.R.), and the Department of Nutrition, Harvard T.H. Chan School of Public Health (K.J., L.B., F.M.S.) - all in Boston
| |
Collapse
|
20
|
Ellouze I, Sheffler J, Nagpal R, Arjmandi B. Dietary Patterns and Alzheimer's Disease: An Updated Review Linking Nutrition to Neuroscience. Nutrients 2023; 15:3204. [PMID: 37513622 PMCID: PMC10384681 DOI: 10.3390/nu15143204] [Citation(s) in RCA: 12] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 07/15/2023] [Accepted: 07/17/2023] [Indexed: 07/30/2023] Open
Abstract
Alzheimer's disease (AD) is a growing concern for the aging population worldwide. With no current cure or reliable treatments available for AD, prevention is an important and growing area of research. A range of lifestyle and dietary patterns have been studied to identify the most effective preventive lifestyle changes against AD and related dementia (ADRD) pathology. Of these, the most studied dietary patterns are the Mediterranean, DASH, MIND, ketogenic, and modified Mediterranean-ketogenic diets. However, there are discrepancies in the reported benefits among studies examining these dietary patterns. We herein compile a narrative/literature review of existing clinical evidence on the association of these patterns with ADRD symptomology and contemplate their preventive/ameliorative effects on ADRD neuropathology in various clinical milieus. By and large, plant-based dietary patterns have been found to be relatively consistently and positively correlated with preventing and reducing the odds of ADRD. These impacts stem not only from the direct impact of specific dietary components within these patterns on the brain but also from indirect effects through decreasing the deleterious effects of ADRD risk factors, such as diabetes, obesity, and cardiovascular diseases. Importantly, other psychosocial factors influence dietary intake, such as the social connection, which may directly influence diet and lifestyle, thereby also impacting ADRD risk. To this end, prospective research on ADRD should include a holistic approach, including psychosocial considerations.
Collapse
Affiliation(s)
- Ines Ellouze
- Department of Plant Biotechnology, Higher Institute of Biotechnology of Beja, University of Jendouba, Beja 382, Tunisia;
- Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA
| | - Julia Sheffler
- Center for Translational Behavioral Science, Florida State University College of Medicine, Tallahassee, FL 32304, USA;
| | - Ravinder Nagpal
- Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA
- Center for Advancing Exercise and Nutrition Research on Aging, Florida State University, Tallahassee, FL 32306, USA
| | - Bahram Arjmandi
- Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, FL 32306, USA
- Center for Advancing Exercise and Nutrition Research on Aging, Florida State University, Tallahassee, FL 32306, USA
| |
Collapse
|
21
|
Patel PR, Armistead-Jehle P, Eltman NR, Heath KM, Cifu DX, Swanson RL. Brain Injury: How Dietary Patterns Impact Long-Term Outcomes. CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS 2023; 11:367-376. [PMID: 37732170 PMCID: PMC10506931 DOI: 10.1007/s40141-023-00413-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2023] [Indexed: 09/22/2023]
Abstract
Purpose of Review Individuals with a history of traumatic brain injury (TBI) are at a much greater risk for developing cardiovascular disease (CVD) compared to the general population. This review discusses dietary patterns as a means of addressing modifiable risk factors following TBI exposure. Evidence-based resources for practicing Physiatrists and Brain Injury Medicine specialists pertaining to nutrition education and counseling are also provided. Recent Findings We examined Mediterranean, Dietary Approaches to Stop Hypertension, plant-based, ketogenic, and intermittent fasting dietary patterns through publications of clinical trials and systematic reviews. While many reviews had significant positive findings, some were limited by generalizability. Summary While there is extensive literature on the immediate nutrition goals in the inpatient setting following an acute TBI exposure, there is limited literature discussing the nature of diet and nutrition in the post-acute setting. Fortunately, most individuals with TBI exposure survive their initial injury and continue into the recovery phase. The scientific literature supports increased morbidity and mortality with chronic TBI exposure compared to matched counterparts, most notably with CVD. A diet rich in fiber and nutrients but limited in added sugars, saturated fats, and excess calories would likely have the greatest cardiovascular and related neurologic protection. Future studies are needed to assess the specific impact of dietary interventions in the chronic phase of brain injury recovery.
Collapse
Affiliation(s)
- Palak R. Patel
- Department of Physical Medicine and Rehabilitation, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
| | | | - Nicholas R. Eltman
- Corporal Michael J. Crescenz VA Medical Center, Center for Neurotrauma, Neurodegeneration, and Restoration, Philadelphia, PA USA
- Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ USA
| | - Kelly M. Heath
- Department of Physical Medicine and Rehabilitation, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
- Rehab Medicine Service, Corporal Michael J. Crescenz VA Medical Center, 3900 Woodland Avenue, Mail Stop #117, Philadelphia, PA 19104 USA
| | - David X. Cifu
- Physical Medicine and Rehabilitation, Virginia Commonwealth University School of Medicine, Richmond, USA
- Physical Medicine and Rehabilitation, Central Virginia Veterans Health Care System, Richmond, USA
| | - Randel L. Swanson
- Department of Physical Medicine and Rehabilitation, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
- Corporal Michael J. Crescenz VA Medical Center, Center for Neurotrauma, Neurodegeneration, and Restoration, Philadelphia, PA USA
- Rehab Medicine Service, Corporal Michael J. Crescenz VA Medical Center, 3900 Woodland Avenue, Mail Stop #117, Philadelphia, PA 19104 USA
| |
Collapse
|
22
|
Chen H, Dhana K, Huang Y, Huang L, Tao Y, Liu X, Melo van Lent D, Zheng Y, Ascherio A, Willett W, Yuan C. Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia. JAMA Psychiatry 2023; 80:630-638. [PMID: 37133875 PMCID: PMC10157510 DOI: 10.1001/jamapsychiatry.2023.0800] [Citation(s) in RCA: 24] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Accepted: 02/20/2023] [Indexed: 05/04/2023]
Abstract
Importance Dementia threatens the well-being of older adults, making efforts toward prevention of great importance. Objective To evaluate the association of the Mediterranean-Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet with the risk of dementia in 3 prospective studies and a meta-analysis. Design, Setting, and Participants Cohort analyses included the Whitehall II study (WII), the Health and Retirement Study (HRS), and the Framingham Heart Study Offspring cohort (FOS), and the meta-analysis included 11 cohort studies. Participants were middle-aged and older women and men from WII in 2002 to 2004, HRS in 2013, and FOS in 1998 to 2001 without dementia at the study baseline. Data were analyzed from May 25 to September 1, 2022. Exposures MIND diet score was measured using food frequency questionnaires, and scores ranged from 0 to 15, with a higher score indicating higher adherence to the MIND diet. Main Outcome and Measures Incident all-cause dementia, with cohort-specific definitions. Results Included in this study were 8358 participants (mean [SD] age, 62.2 [6.0] years; 5777 male [69.1%]) from WII, 6758 participants (mean [SD] age, 66.5 [10.4] years; 3965 female [58.7%]) from HRS, and 3020 participants (mean [SD] age, 64.2 [9.1] years; 1648 female [54.6%]) from FOS. The mean (SD) baseline MIND diet score was 8.3 (1.4) in WII, 7.1 (1.9) in HRS, and 8.1 (1.6) in FOS. Over 166 516 person-years, a total of 775 participants (220 in WII, 338 in HRS, and 217 in FOS) developed incident dementia. In the multivariable-adjusted Cox proportional hazard model, higher MIND diet score was associated with lower risk of dementia (pooled hazard ratio [HR] for every 3-point increment, 0.83; 95% CI, 0.72-0.95; P for trend = .01; I2 = 0%). The associations were consistently observed in subgroups defined by sex, age, smoking status, and body mass index. In the meta-analysis of 11 cohort studies with 224 049 participants (5279 incident dementia cases), the highest tertile of MIND diet score was associated with lower risk of dementia compared with the lowest tertile (pooled HR, 0.83; 95% CI, 0.76-0.90; I2 = 35%). Conclusions and Relevance Results suggest that adherence to the MIND diet was associated with lower risk of incident dementia in middle-aged and older adults. Further studies are warranted to develop and refine the specific MIND diet for different populations.
Collapse
Affiliation(s)
- Hui Chen
- School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Klodian Dhana
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois
- Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois
| | - Yuhui Huang
- School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Liyan Huang
- School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yang Tao
- School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xiaoran Liu
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois
- Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois
| | - Debora Melo van Lent
- Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
- Framingham Heart Study, Framingham, Massachusetts
| | - Yan Zheng
- State Key Laboratory of Genetic Engineering, Human Phenome Institute, and School of Life Sciences, Fudan University, Shanghai, China
| | - Alberto Ascherio
- Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
| | - Walter Willett
- Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
| | - Changzheng Yuan
- School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
| |
Collapse
|
23
|
Key MN, Szabo-Reed AN. Impact of Diet and Exercise Interventions on Cognition and Brain Health in Older Adults: A Narrative Review. Nutrients 2023; 15:2495. [PMID: 37299458 PMCID: PMC10255782 DOI: 10.3390/nu15112495] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Revised: 05/15/2023] [Accepted: 05/24/2023] [Indexed: 06/12/2023] Open
Abstract
The ability to preserve cognitive function and protect brain structure from the effects of the aging process and neurodegenerative disease is the goal of non-pharmacologic, lifestyle interventions focused on brain health. This review examines, in turn, current diet and exercise intervention trends and the collective progress made toward understanding their impact on cognition and brain health. The diets covered in this review include the Mediterranean diet (MeDi), Dietary Approaches to Stop Hypertension (DASH), Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND), ketogenic diet, intermittent fasting, and weight loss management. The exercise approaches covered in this review include endurance, resistance, combined exercise programs, yoga, tai chi, and high-intensity interval training. Although valuable evidence is building concerning how diet and exercise influence cognitive performance and brain structure, many of the open questions in the field are concerned with why we see these effects. Therefore, more strategically designed intervention studies are needed to reveal the likely multiple mechanisms of action in humans.
Collapse
Affiliation(s)
- Mickeal N. Key
- KU Alzheimer’s Disease Research Center, Fairway, KS 66205, USA;
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Amanda N. Szabo-Reed
- KU Alzheimer’s Disease Research Center, Fairway, KS 66205, USA;
- Department of Internal Medicine, Division of Physical Activity and Weight Management, University of Kansas Medical Center, Kansas City, KS 66160, USA
| |
Collapse
|
24
|
Rajado AT, Silva N, Esteves F, Brito D, Binnie A, Araújo IM, Nóbrega C, Bragança J, Castelo-Branco P. How can we modulate aging through nutrition and physical exercise? An epigenetic approach. Aging (Albany NY) 2023. [DOI: https:/doi.org/10.18632/aging.204668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/01/2023]
Affiliation(s)
- Ana Teresa Rajado
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Nádia Silva
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Filipa Esteves
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - David Brito
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Alexandra Binnie
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Department of Critical Care, William Osler Health System, Etobicoke, Ontario, Canada
| | - Inês M. Araújo
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - Clévio Nóbrega
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - José Bragança
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - Pedro Castelo-Branco
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | | |
Collapse
|
25
|
Rajado AT, Silva N, Esteves F, Brito D, Binnie A, Araújo IM, Nóbrega C, Bragança J, Castelo-Branco P. How can we modulate aging through nutrition and physical exercise? An epigenetic approach. Aging (Albany NY) 2023; 15:3191-3217. [PMID: 37086262 DOI: 10.18632/aging.204668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Accepted: 03/11/2023] [Indexed: 04/23/2023]
Abstract
The World Health Organization predicts that by 2050, 2.1 billion people worldwide will be over 60 years old, a drastic increase from only 1 billion in 2019. Considering these numbers, strategies to ensure an extended "healthspan" or healthy longevity are urgently needed. The present study approaches the promotion of healthspan from an epigenetic perspective. Epigenetic phenomena are modifiable in response to an individual's environmental exposures, and therefore link an individual's environment to their gene expression pattern. Epigenetic studies demonstrate that aging is associated with decondensation of the chromatin, leading to an altered heterochromatin structure, which promotes the accumulation of errors. In this review, we describe how aging impacts epigenetics and how nutrition and physical exercise can positively impact the aging process, from an epigenetic point of view. Canonical histones are replaced by histone variants, concomitant with an increase in histone post-translational modifications. A slight increase in DNA methylation at promoters has been observed, which represses transcription of previously active genes, in parallel with global genome hypomethylation. Aging is also associated with deregulation of gene expression - usually provided by non-coding RNAs - leading to both the repression of previously transcribed genes and to the transcription of previously repressed genes. Age-associated epigenetic events are less common in individuals with a healthy lifestyle, including balanced nutrition, caloric restriction and physical exercise. Healthy aging is associated with more tightly condensed chromatin, fewer PTMs and greater regulation by ncRNAs.
Collapse
Affiliation(s)
- Ana Teresa Rajado
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Nádia Silva
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Filipa Esteves
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - David Brito
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
| | - Alexandra Binnie
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Department of Critical Care, William Osler Health System, Etobicoke, Ontario, Canada
| | - Inês M Araújo
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - Clévio Nóbrega
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - José Bragança
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| | - Pedro Castelo-Branco
- Algarve Biomedical Center, Research Institute (ABC-RI), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Algarve Biomedical Center (ABC), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Faculty of Medicine and Biomedical Sciences (FMCB), University of Algarve Campus Gambelas, Faro 8005-139, Portugal
- Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal
| |
Collapse
|
26
|
Arnoldy L, Gauci S, Young LM, Marx W, Macpherson H, Pipingas A, Civier O, White DJ. The association of dietary and nutrient patterns on neurocognitive decline: A systematic review of MRI and PET studies. Ageing Res Rev 2023; 87:101892. [PMID: 36878405 DOI: 10.1016/j.arr.2023.101892] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Revised: 02/14/2023] [Accepted: 02/27/2023] [Indexed: 03/08/2023]
Abstract
BACKGROUND As the global population ages, there has been a growing incidence of neurodegenerative diseases such as Alzheimer's. More recently, studies exploring the relationship between dietary patterns and neuroimaging outcomes have received particular attention. This systematic literature review provides a structured overview of the association between dietary and nutrient patterns on neuroimaging outcomes and cognitive markers in middle-aged to older adults. A comprehensive literature search was conducted to find relevant articles published from 1999 to date using the following databases Ovid MEDLINE, Embase, PubMed, Scopus and Web of Science. The inclusion criteria for the articles comprised studies reporting on the association between dietary patterns and neuroimaging outcomes, which includes both specific pathological hallmarks of neurodegenerative diseases such as Aβ and tau and nonspecific markers such as structural MRI and glucose metabolism. The risk of bias was evaluated using the Quality Assessment tool from the National Heart, Lung, and Blood Institute of the National Institutes of Health. The results were then organized into a summary of results table, collated based on synthesis without meta-analysis. After conducting the search, 6050 records were extracted and screened for eligibility, with 107 eligible for full-text screening and 42 articles ultimately being included in this review. The results of the systematic review indicate that there is some evidence suggesting that healthy dietary and nutrient patterns were associated with neuroimaging measures, indicative of a protective influence on neurodegeneration and brain ageing. Conversely, unhealthy dietary and nutrient patterns showed evidence pointing to decreased brain volumes, poorer cognition and increased Aβ deposition. Future research should focus on sensitive neuroimaging acquisition and analysis methods, to study early neurodegenerative changes and identify critical periods for interventions and prevention. SYSTEMATIC REVIEW REGISTRATION PROSPERO registration no, CRD42020194444).
Collapse
Affiliation(s)
- Lizanne Arnoldy
- Centre of Human Psychopharmacology, Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne Australia.
| | - Sarah Gauci
- Centre of Human Psychopharmacology, Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne Australia; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Deakin University, Geelong, Australia
| | - Lauren M Young
- Centre of Human Psychopharmacology, Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne Australia; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Deakin University, Geelong, Australia
| | - Wolfgang Marx
- IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Deakin University, Geelong, Australia
| | - Helen Macpherson
- Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia
| | - Andrew Pipingas
- Centre of Human Psychopharmacology, Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne Australia
| | - Oren Civier
- Swinburne Neuroimaging, Swinburne University, Melbourne, Australia
| | - David J White
- Centre of Human Psychopharmacology, Centre for Mental Health and Brain Sciences, Swinburne University, Melbourne Australia; Swinburne Neuroimaging, Swinburne University, Melbourne, Australia
| |
Collapse
|
27
|
Andriambelo B, Stiffel M, Roke K, Plourde M. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review. Ageing Res Rev 2023; 85:101835. [PMID: 36603691 DOI: 10.1016/j.arr.2022.101835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 12/05/2022] [Accepted: 12/21/2022] [Indexed: 01/03/2023]
Abstract
Long chain polyunsaturated omega-3 fatty acids (n-3 FA), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to be important components in a healthy diet and contribute to healthy functioning of the heart and the brain, among other organs. Although there are epidemiological studies on the strong relationship between fish or n-3 FA consumption and lower risk of cognitive decline, results from randomized controlled trials (RCTs) are less consistent. Here, we performed a scoping review on RCTs with n-3 FA supplementation where cognition was evaluated. Seventy-eight RCTs published before April 2022 were included in this review. Among these RCTs, 43.6% reported a positive cognitive outcome after the consumption of n-3 FA compared to the placebo. However, there was a large diversity of populations studied (age ranges and health status), wide range of doses of EPA + DHA supplemented (79 mg/day - 5200 mg/day) and a multitude of tests evaluating cognition, mainly diagnostic tests, that were used to assess cognitive scores and overall cognitive status. RCTs were thereafter categorized into non-cognitively impaired middle-aged adults (n = 24), non-cognitively impaired older adults (n = 24), adults with subjective memory complaints (n = 14), adults with mild cognitive impairments (MCI, n = 9) and people with diagnosed dementia or other cognitive changes (n = 7). Among these categories, 66.7% of RCTs conducted with MCI adults reported a positive cognitive outcome when supplemented with n-3 FA vs. the placebo. Therefore, this scoping review provides rationale and questions to a) strengthen the design of future RCTs with n-3 FA for cognitive outcomes, and b) generate more informative data to support clinicians in their practice in assessing cognition before and after a nutritional intervention.
Collapse
Affiliation(s)
- B Andriambelo
- Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada, Centre de Recherche sur le Vieillissement, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada; Institut de la nutrition et des aliments fonctionnels, Université Laval, QC, Canada
| | - M Stiffel
- Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada, Centre de Recherche sur le Vieillissement, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada; Institut de la nutrition et des aliments fonctionnels, Université Laval, QC, Canada
| | - K Roke
- GOED- Global Organization for EPA and DHA Omega-3, Salt Lake City, UT, United States
| | - M Plourde
- Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada, Centre de Recherche sur le Vieillissement, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada; Institut de la nutrition et des aliments fonctionnels, Université Laval, QC, Canada.
| |
Collapse
|
28
|
Rao RV, Subramaniam KG, Gregory J, Bredesen AL, Coward C, Okada S, Kelly L, Bredesen DE. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review. Int J Mol Sci 2023; 24:ijms24021659. [PMID: 36675177 PMCID: PMC9865291 DOI: 10.3390/ijms24021659] [Citation(s) in RCA: 26] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Revised: 01/03/2023] [Accepted: 01/09/2023] [Indexed: 01/18/2023] Open
Abstract
Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative disease typically characterized by memory loss, personality changes, and a decline in overall cognitive function. Usually manifesting in individuals over the age of 60, this is the most prevalent type of dementia and remains the fifth leading cause of death among Americans aged 65 and older. While the development of effective treatment and prevention for AD is a major healthcare goal, unfortunately, therapeutic approaches to date have yet to find a treatment plan that produces long-term cognitive improvement. Drugs that may be able to slow down the progression rate of AD are being introduced to the market; however, there has been no previous solution for preventing or reversing the disease-associated cognitive decline. Recent studies have identified several factors that contribute to the progression and severity of the disease: diet, lifestyle, stress, sleep, nutrient deficiencies, mental health, socialization, and toxins. Thus, increasing evidence supports dietary and other lifestyle changes as potentially effective ways to prevent, slow, or reverse AD progression. Studies also have demonstrated that a personalized, multi-therapeutic approach is needed to improve metabolic abnormalities and AD-associated cognitive decline. These studies suggest the effects of abnormalities, such as insulin resistance, chronic inflammation, hypovitaminosis D, hormonal deficiencies, and hyperhomocysteinemia, in the AD process. Therefore a personalized, multi-therapeutic program based on an individual's genetics and biochemistry may be preferable over a single-drug/mono-therapeutic approach. This article reviews these multi-therapeutic strategies that identify and attenuate all the risk factors specific to each affected individual. This article systematically reviews studies that have incorporated multiple strategies that target numerous factors simultaneously to reverse or treat cognitive decline. We included high-quality clinical trials and observational studies that focused on the cognitive effects of programs comprising lifestyle, physical, and mental activity, as well as nutritional aspects. Articles from PubMed Central, Scopus, and Google Scholar databases were collected, and abstracts were reviewed for relevance to the subject matter. Epidemiological, pathological, toxicological, genetic, and biochemical studies have all concluded that AD represents a complex network insufficiency. The research studies explored in this manuscript confirm the need for a multifactorial approach to target the various risk factors of AD. A single-drug approach may delay the progression of memory loss but, to date, has not prevented or reversed it. Diet, physical activity, sleep, stress, and environment all contribute to the progression of the disease, and, therefore, a multi-factorial optimization of network support and function offers a rational therapeutic strategy. Thus, a multi-therapeutic program that simultaneously targets multiple factors underlying the AD network may be more effective than a mono-therapeutic approach.
Collapse
Affiliation(s)
- Rammohan V. Rao
- Apollo Health, Burlingame, CA 94011, USA
- Correspondence: (R.V.R.); (D.E.B.)
| | | | | | | | | | - Sho Okada
- Apollo Health, Burlingame, CA 94011, USA
| | | | - Dale E. Bredesen
- Apollo Health, Burlingame, CA 94011, USA
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90024, USA
- Correspondence: (R.V.R.); (D.E.B.)
| |
Collapse
|
29
|
Abstract
BACKGROUND Alzheimer's disease (AD) plagues 6.5 million Americans 65+, yet treatments are lacking. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has been developed to address the expansive impact of dementias on the general public. This systematic review evaluated the impact of the MIND diet on cognition in those with pathologies across the dementia spectrum. OBJECTIVE To evaluate the application of the MIND diet for prevention and/or treatment of dementia. METHODS PubMed was used to conduct a search using the MIND diet and terms related to cognition. Articles were excluded if they were published prior to 2018, studied a population without dementia or significant risk factors, or did not include those 65 + . The overall quality of each source was analyzed based on the cognitive test(s) used, the selection of subjects, and the sample size. RESULTS The search generated 33 papers, which yielded 11 articles after screening. Of these studies, one was conducted on those with mild cognitive impairment, one with AD, two with general dementia, and seven with at-risk individuals. All the studies found a positive correlation between adherence and some form of cognitive functioning, but results were mixed for specific cognitive domains. CONCLUSIONS These findings suggest that the MIND diet may be a useful long-term treatment option for those with various dementia pathologies. However, more research is needed on subjects with onset dementias. Additionally, there is a need for more research into the mechanisms behind the common comorbidities.
Collapse
Affiliation(s)
- Elizabeth Healy
- James Madison University, College of Health and Behavioral Studies, Harrisonburg, VA, USA
| |
Collapse
|
30
|
Garrido-Dzib AG, Chávez-Loría G, Magallón-Zertuche V, Avila-Nava A, Palacios-González B, Gutiérrez-Solis AL. Micro- and Macronutrient Intake and Food Group Frequency Consumed by Subjects with Cognitive Impairment and Dementia in Latin America: A Systematic Review. J Alzheimers Dis 2023; 94:425-439. [PMID: 37302035 PMCID: PMC10357157 DOI: 10.3233/jad-230231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/06/2023] [Indexed: 06/12/2023]
Abstract
BACKGROUND Nutrition has relevant role in the pathogenesis of dementia. However, in Latin American Countries (LAC), it is unknown which type of diet the subjects with dementia and cognitive dysfunction have. OBJECTIVE The main purpose of this study was to determine micro- and macronutrients and food frequency intake among the LAC population with mild cognitive impairment (MCI) and dementia. METHODS A systematic review using PubMed, Cochrane, Lilacs, and Scielo databases. Energy intake as well as micro- and macronutrients intake were analyzed using a random-effect model and presented in a forest plot. RESULTS Nine articles were included, an estimated energy intake of 1598.47 kcal (95% CI 1351.07-1845.88) was obtained. A daily consumption of 73.64 g/day (95% CI 64.07-83.2) of protein; 262.17 g/day (95% CI 214.51-309.93) of carbohydrates, and 57.91 g/day (95% CI 49.16-66.66) of fats were reported. A micronutrients daily intake consumption of 201.35μg/day of vitamin B9 (95% CI 125.32-277.38); 5.61μg/day of vitamin B12 (95% CI 2.53-8.70), and 139.67 mg/day of vitamin C (95% CI 59.33-220.02). Mineral intake of 637.32 mg/day of calcium (95% CI 288.54-986.11) and 9 mg/day of iron (95% CI 2.28-15.71) was obtained. A low intake of fruits and vegetables was found. CONCLUSION Individuals with MCI and dementia from LAC have a nutritional deficiency characterized by a lower intake of fruits and vegetables, a high consumption of carbohydrates and protein, adequate fats intake and vitamins B12, vitamin C, and iron consumption, but a low intake of vitamin B9 and calcium.
Collapse
Affiliation(s)
- Angel Gabriel Garrido-Dzib
- Hospital Regional de Alta Especialidad de la Península de Yucatán (HRAEPY), Mérida, Yucatán, Mexico
- Facultad de Medicina, Universidad Autónoma de Yucatán (UADY), Mérida, Yucatán, Mexico
| | - Geovanni Chávez-Loría
- Hospital Regional de Alta Especialidad de la Península de Yucatán (HRAEPY), Mérida, Yucatán, Mexico
| | - Valeria Magallón-Zertuche
- Hospital Regional de Alta Especialidad de la Península de Yucatán (HRAEPY), Mérida, Yucatán, Mexico
- Becario de la Dirección General de Calidad y Educación en Salud (DGCES), Secretaría de Salud, Ciudad de México, Mexico
| | - Azalia Avila-Nava
- Hospital Regional de Alta Especialidad de la Península de Yucatán (HRAEPY), Mérida, Yucatán, Mexico
| | - Berenice Palacios-González
- Laboratorio de envejecimiento saludable del Instituto Nacional de Medicina Genómica (INMEGEN), Centro de Investigación sobre el Envejecimiento, Ciudad de México, Mexico
| | | |
Collapse
|
31
|
Wang K, Yang R, Chen TT, Qin MR, Wang P, Kong MW. Therapeutic Mechanism of Kai Xin San on Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation. Chin J Integr Med 2022; 29:413-423. [PMID: 36474082 DOI: 10.1007/s11655-022-3589-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/01/2022] [Indexed: 12/12/2022]
Abstract
OBJECTIVE To explore the specific pharmacological molecular mechanisms of Kai Xin San (KXS) on treating Alzheimer's disease (AD) based on network pharmacology and experimental validation. METHODS The chemical compounds of KXS and their corresponding targets were screened using the Encyclopedia of Traditional Chinese Medicine (ETCM) database. AD-related target proteins were obtained from MalaCards database and DisGeNET databases. Key compounds and targets were identified from the compound-target-disease network and protein-protein interaction (PPI) network analysis. Functional enrichment analysis predicted the potential key signaling pathways involved in the treatment of AD with KXS. The binding affinities between key ingredients and targets were further verified using molecular docking. Finally, the predicted key signaling pathway was validated experimentally. Positioning navigation and space search experiments were conducted to evaluate the cognitive improvement effect of KXS on AD rats. Western blot was used to further examine and investigate the expression of the key target proteins related to the predicted pathway. RESULTS In total, 38 active compounds and 469 corresponding targets of KXS were screened, and 264 target proteins associated with AD were identified. The compound-target-disease and PPI networks identified key active ingredients and protein targets. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis suggested a potential effect of KXS in the treatment of AD via the amyloid beta (A β)-glycogen synthase kinase-3 beta (GSK3 β)-Tau pathway. Molecular docking revealed a high binding affinity between the key ingredients and targets. In vivo, KXS treatment significantly improved cognitive deficits in AD rats induced by Aβ1-42, decreased the levels of Aβ, p-GSK3β, p-Tau and cyclin-dependent kinase 5, and increased the expressions of protein phosphatase 1 alpha (PP1A) and PP2A (P<0.05 or P<0.01). CONCLUSION KXS exerted neuroprotective effects by regulating the Aβ -GSK3β-Tau signaling pathway, which provides novel insights into the therapeutic mechanism of KXS and a feasible pharmacological strategy for the treatment of AD.
Collapse
|
32
|
Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Res Rev 2022; 82:101777. [PMID: 36336171 DOI: 10.1016/j.arr.2022.101777] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 09/02/2022] [Accepted: 10/30/2022] [Indexed: 11/06/2022]
Abstract
Dementia prevention research has progressed rapidly in recent years, with publication of several large lifestyle intervention trials, and renewed interest in pharmacological interventions, notably for individuals with Alzheimer's disease biomarkers, warranting an updated review of results and methodology. We identified 112 completed trials testing the efficacy of single-domain pharmacological (n = 33, 29%), nutritional (n = 27, 24%), physical activity (n = 18, 16%) and cognitive stimulation (n = 13, 12%), or multidomain (n = 22, 20%) interventions on incident dementia, or a relevant intermediate marker (e.g. cognitive function, biomarkers or dementia risk scores) in people without dementia. The earliest trials tested pharmacological interventions or nutritional supplements, but lifestyle interventions predominated in the last decade. In total, 21 (19%) trials demonstrated a clear beneficial effect on the pre-specified primary outcome (or all co-primary outcomes), but only two (10%) were large-scale (testing blood pressure lowering (Syst-Eur) or multidomain (FINGER) interventions on incident dementia and cognitive change in cognitive function, respectively). Of the 116 ongoing trials, 40% (n = 46) are testing multidomain interventions. Recent methodological shifts concern target populations, primary outcome measures, and intervention design, but study design remains constant (parallel group randomised controlled trial). Future trials may consider using adaptive trials or interventions, and more targeted approaches, since certain interventions may be more effective in certain subgroups of the population, and at specific times in the life-course. Efforts should also be made to increase the representativeness and diversity of prevention trial populations.
Collapse
Affiliation(s)
- Nicola Coley
- Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.
| | - Caroline Giulioli
- Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France
| | - Paul S Aisen
- Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, CA, USA
| | - Bruno Vellas
- Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France; Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital, France
| | - Sandrine Andrieu
- Center for Epidemiology and Research in Population Health (CERPOP), University of Toulouse, INSERM UMR1295, UPS, Toulouse, France; Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France; Department of Internal Medicine, Division of General Internal and Geriatric Medicine, University of New Mexico, USA
| |
Collapse
|
33
|
Hunt NJ, Wahl D, Westwood LJ, Lockwood GP, Le Couteur DG, Cogger VC. Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics. Adv Drug Deliv Rev 2022; 190:114537. [PMID: 36115494 PMCID: PMC10125004 DOI: 10.1016/j.addr.2022.114537] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 09/04/2022] [Accepted: 09/07/2022] [Indexed: 01/24/2023]
Abstract
Many people living with dementia and cognitive impairment have dysfunctional mitochondrial and insulin-glucose metabolism resembling type 2 diabetes mellitus and old age. Evidence from human trials shows that nutritional interventions and anti-diabetic medicines that target nutrient-sensing pathways overcome these deficits in glucose and energy metabolism and can improve cognition and/or reduce symptoms of dementia. The liver is the main organ that mediates the systemic effects of diets and many diabetic medicines; therefore, it is an intermediate target for such dementia interventions. A challenge is the efficacy of these treatments in older age. Solutions include the targeted hepatic delivery of diabetic medicines using nanotechnologies and titration of macronutrients to optimize hepatic energy metabolism.
Collapse
Affiliation(s)
- Nicholas J Hunt
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2008, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2008, Australia; Sydney Nano Institute, The University of Sydney, Sydney, NSW 2008, Australia; ANZAC Research Institute & Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, NSW 2139, Australia
| | - Devin Wahl
- Department of Health and Exercise Science & Centre for Healthy Aging, Colorado State University, CO 80523, United States
| | - Lara J Westwood
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2008, Australia; ANZAC Research Institute & Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, NSW 2139, Australia
| | - Glen P Lockwood
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2008, Australia; ANZAC Research Institute & Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, NSW 2139, Australia
| | - David G Le Couteur
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2008, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2008, Australia; ANZAC Research Institute & Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, NSW 2139, Australia
| | - Victoria C Cogger
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2008, Australia; ANZAC Research Institute & Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, NSW 2139, Australia.
| |
Collapse
|
34
|
Piemontese L, Brunetti L, Leuci R. Can foods influence the onset and progress of neurodegenerative diseases? Neural Regen Res 2022; 17:2443-2444. [PMID: 35535892 PMCID: PMC9120676 DOI: 10.4103/1673-5374.335810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 11/18/2021] [Accepted: 12/18/2021] [Indexed: 12/04/2022] Open
Affiliation(s)
- Luca Piemontese
- Department of Pharmacy and Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Italy
| | - Leonardo Brunetti
- Department of Pharmacy and Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Italy
| | - Rosalba Leuci
- Department of Pharmacy and Pharmaceutical Sciences, University of Bari Aldo Moro, Bari, Italy
| |
Collapse
|
35
|
Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders. Nutrients 2022; 14:nu14193967. [PMID: 36235622 PMCID: PMC9571089 DOI: 10.3390/nu14193967] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2022] [Revised: 09/20/2022] [Accepted: 09/21/2022] [Indexed: 11/30/2022] Open
Abstract
Herein we gathered updated knowledge regarding the alterations of gut microbiota (dysbiosis) and its correlation with human neurodegenerative and brain-related diseases, e.g., Alzheimer’s and Parkinson’s. This review underlines the importance of gut-derived metabolites and gut metabolic status as the main players in gut-brain crosstalk and their implications on the severity of neural conditions. Scientific evidence indicates that the administration of probiotic bacteria exerts beneficial and protective effects as reduced systemic inflammation, neuroinflammation, and inhibited neurodegeneration. The experimental results performed on animals, but also human clinical trials, show the importance of designing a novel microbiota-based probiotic dietary supplementation with the aim to prevent or ease the symptoms of Alzheimer’s and Parkinson’s diseases or other forms of dementia or neurodegeneration.
Collapse
|
36
|
Yassine HN, Samieri C, Livingston G, Glass K, Wagner M, Tangney C, Plassman BL, Ikram MA, Voigt RM, Gu Y, O’Bryant S, Minihane AM, Craft S, Fink HA, Judd S, Andrieu S, Bowman GL, Richard E, Albensi B, Meyers E, Khosravian S, Solis M, Carrillo M, Snyder H, Grodstein F, Scarmeas N, Schneider LS. Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group. THE LANCET. HEALTHY LONGEVITY 2022; 3:e501-e512. [PMID: 35821792 PMCID: PMC9273104 DOI: 10.1016/s2666-7568(22)00120-9] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Observational studies suggest that nutritional factors have a potential cognitive benefit. However, systematic reviews of randomised trials of dietary and nutritional supplements have reported largely null effects on cognitive outcomes and have highlighted study inconsistencies and other limitations. In this Personal View, the Nutrition for Dementia Prevention Working Group presents what we consider to be limitations in the existing nutrition clinical trials for dementia prevention. On the basis of this evidence, we propose recommendations for incorporating dietary patterns and the use of genetic, and nutrition assessment tools, biomarkers, and novel clinical trial designs to guide future trial developments. Nutrition-based research has unique challenges that could require testing both more personalised interventions in targeted risk subgroups, identified by nutritional and other biomarkers, and large-scale and pragmatic study designs for more generalisable public health interventions across diverse populations.
Collapse
Affiliation(s)
| | | | - Gill Livingston
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Kimberly Glass
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Maude Wagner
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Christy Tangney
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Brenda L Plassman
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - M Arfan Ikram
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Robin M Voigt
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Yian Gu
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Sid O’Bryant
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Anne Marie Minihane
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Suzanne Craft
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Howard A Fink
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Suzanne Judd
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Sandrine Andrieu
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Gene L Bowman
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Edo Richard
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Benedict Albensi
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Emily Meyers
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Serly Khosravian
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Michele Solis
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Maria Carrillo
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | - Heather Snyder
- Department of Medicine (H N Yassine MD) and Department of Neurology (H
N Yassine, Prof L S Schneider MD MS), Department of Psychiatry and Neuroscience
(Prof L S Schneider), and Department of Gerontology (Prof L S Schneider), Keck
School of Medicine and Department of Medicine (S Khosravian BA), University of
Southern California, Los Angeles, CA, USA; Bordeaux population health U1219,
National Institute of Health and Medical Research (INSERM)—University of
Bordeaux, Bordeaux, France (C Samieri PhD); Division of Psychiatry, University
College London, London, UK (G Livingston MD); Camden and Islington NHS
Foundation Trust, London, UK (G Livingston); Channing Division of Network
Medicine, Brigham and Women’s Hospital, Boston MA, USA (K Glass PhD);
Department of Medicine, Harvard Medical School (K Glass) and Department of
Biostatistics, Harvard Chan School of Public Health (K Glass), Harvard
University, Boston MA, USA; Rush Alzheimer’s Disease Center (M Wagner
PhD, F Grodstein ScD), Departments of Clinical Nutrition and Preventive Medicine
(C Tangney PhD), Rush Center for Microbiome and Chronobiology Research (R M
Voigt PhD), Department of Internal Medicine (R M Voigt), and Department of
Anatomy and Cell Biology (R M Voigt), Rush University Medical Center (M Wagner)
and Department of Neurological Sciences (M Wagner), Rush Medical College, Rush
University, Chicago IL, USA; Department of Psychiatry and Behavioral Sciences,
Duke University, Durham NC, USA (B L Plassman PhD); Department of Epidemiology,
Erasmus MC University Medical Center, Rotterdam, Netherlands (M A Ikram MD PhD);
Department of Neurology and Department of Epidemiology, Taub Institute,
Sergievsky Center, Columbia University Irving Medical Center (Y Gu MD PhD), and
Department of Neurology (N Scarmeas MD), Colombia University, New York, NY, USA;
University of North Texas Health Science Center, University of North Texas, Fort
Worth, Texas TX, USA (S O’Bryant PhD); Norwich Medical School (A M
Minihane PhD) and Norwich Institute of Healthy Ageing (A M Minihane), University
of East Anglia, Norwich, UK; Department of Internal Medicine-Geriatrics, Wake
Forest University School of Medicine, Wake Forest University, Wake Forest, NC,
USA (S Craft PhD); Geriatric Research Education and Clinical Center, Minneapolis
VA Health Care System, Minneapolis, MN, USA (H A Fink MD MPH); Biostatistics
School of Public Health, University of Alabama at Birmingham, Birmingham AL, USA
(S Judd PhD MPH); Aging Research team, Centre for Epidemiology and Research in
Population Health, INSERM (S Andrieu MD PhD) and Department of Clinical
Epidemiology and Public Health, University of Toulouse Hospital, University of
Toulouse III—Paul Sabatier, Toulouse, France (S Andrieu); NIA-Layton
Aging and Alzheimer’s Disease Research Center, Department of Neurology,
Oregon Health and Science University, Portland OR, USA (G L Bowman ND MPH);
Helfgott Research Institute, National University of Natural Medicine, Portland
OR, USA (G L Bowman); Department of Neurology, Donders Institute from Brain,
Behavior and Cognition, Radboud University Medical Centre, Nijmegen, Netherlands
(E Richard MD PhD); Department of Public and Occupational Health, Amsterdam
University Medical Centre, University of Amsterdam, Amsterdam, Netherlands (E
Richard); Department of Pharmaceutical Sciences, College of Pharmacy, Nova
Southeastern University, Davie FL, USA (B Albensi PhD); St Boniface Hospital
Research Center, Winnipeg MB, Canada (B Albensi); Department of Pharmacology and
Therapeutics, University of Manitoba, Winnipeg MB, Canada (B Albensi);
Alzheimer’s Association, Chicago, IL, USA (E Meyers PhD, M Solis PhD, M
Carrillo PhD, H Snyder PhD); Department of Neurology, Aiginitio Hospital,
Medical School, National and Kapodistrian University of Athens, Athens, Greece
(N Scarmeas)
| | | | | | | |
Collapse
|
37
|
Saiyasit N, Butlig EAR, Chaney SD, Traylor MK, Hawley NA, Randall RB, Bobinger HV, Frizell CA, Trimm F, Crook ED, Lin M, Hill BD, Keller JL, Nelson AR. Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease. Front Neurosci 2022; 16:915405. [PMID: 35844216 PMCID: PMC9279126 DOI: 10.3389/fnins.2022.915405] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Accepted: 05/31/2022] [Indexed: 12/13/2022] Open
Abstract
Alzheimer's disease and related dementias (ADRD) are an expanding worldwide crisis. In the absence of scientific breakthroughs, the global prevalence of ADRD will continue to increase as more people are living longer. Racial or ethnic minority groups have an increased risk and incidence of ADRD and have often been neglected by the scientific research community. There is mounting evidence that vascular insults in the brain can initiate a series of biological events leading to neurodegeneration, cognitive impairment, and ADRD. We are a group of researchers interested in developing and expanding ADRD research, with an emphasis on vascular contributions to dementia, to serve our local diverse community. Toward this goal, the primary objective of this review was to investigate and better understand health disparities in Alabama and the contributions of the social determinants of health to those disparities, particularly in the context of vascular dysfunction in ADRD. Here, we explain the neurovascular dysfunction associated with Alzheimer's disease (AD) as well as the intrinsic and extrinsic risk factors contributing to dysfunction of the neurovascular unit (NVU). Next, we ascertain ethnoregional health disparities of individuals living in Alabama, as well as relevant vascular risk factors linked to AD. We also discuss current pharmaceutical and non-pharmaceutical treatment options for neurovascular dysfunction, mild cognitive impairment (MCI) and AD, including relevant studies and ongoing clinical trials. Overall, individuals in Alabama are adversely affected by social and structural determinants of health leading to health disparities, driven by rurality, ethnic minority status, and lower socioeconomic status (SES). In general, these communities have limited access to healthcare and healthy food and other amenities resulting in decreased opportunities for early diagnosis of and pharmaceutical treatments for ADRD. Although this review is focused on the current state of health disparities of ADRD patients in Alabama, future studies must include diversity of race, ethnicity, and region to best be able to treat all individuals affected by ADRD.
Collapse
Affiliation(s)
- Napatsorn Saiyasit
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Evan-Angelo R. Butlig
- Department of Neurology, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Intellectual and Developmental Disabilities Research Center, University of California, Los Angeles, Los Angeles, CA, United States
| | - Samantha D. Chaney
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Miranda K. Traylor
- Department of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United States
| | - Nanako A. Hawley
- Department of Psychology, University of South Alabama, Mobile, AL, United States
| | - Ryleigh B. Randall
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Hanna V. Bobinger
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Carl A. Frizell
- Department of Physician Assistant Studies, University of South Alabama, Mobile, AL, United States
| | - Franklin Trimm
- College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Errol D. Crook
- Department of Internal Medicine, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Mike Lin
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| | - Benjamin D. Hill
- Department of Psychology, University of South Alabama, Mobile, AL, United States
| | - Joshua L. Keller
- Department of Health, Kinesiology, and Sport, University of South Alabama, Mobile, AL, United States
| | - Amy R. Nelson
- Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, United States
| |
Collapse
|
38
|
Soliman TN, Mohammed DM, El-Messery TM, Elaaser M, Zaky AA, Eun JB, Shim JH, El-Said MM. Microencapsulation of Plant Phenolic Extracts Using Complex Coacervation Incorporated in Ultrafiltered Cheese Against AlCl3-Induced Neuroinflammation in Rats. Front Nutr 2022; 9:929977. [PMID: 35845781 PMCID: PMC9278961 DOI: 10.3389/fnut.2022.929977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2022] [Accepted: 06/01/2022] [Indexed: 11/19/2022] Open
Abstract
Plant-derived phenolic compounds have numerous biological effects, including antioxidant, anti-inflammatory, and neuroprotective effects. However, their application is limited because they are degraded under environmental conditions. The aim of this study was to microencapsulate plant phenolic extracts using a complex coacervation method to mitigate this problem. Red beet (RB), broccoli (BR), and spinach leaf (SL) phenolic extracts were encapsulated by complex coacervation. The characteristics of complex coacervates [zeta potential, encapsulation efficiency (EE), FTIR, and morphology] were evaluated. The RB, BR, and SL complex coacervates were incorporated into an ultrafiltered (UF) cheese system. The chemical properties, pH, texture profile, microstructure, and sensory properties of UF cheese with coacervates were determined. In total, 54 male Sprague–Dawley rats were used, among which 48 rats were administered an oral dose of AlCl3 (100 mg/kg body weight/d). Nutritional and biochemical parameters, including malondialdehyde, superoxide dismutase, catalase, reduced glutathione, nitric oxide, acetylcholinesterase, butyrylcholinesterase, dopamine, 5-hydroxytryptamine, brain-derived neurotrophic factor, and glial fibrillary acidic protein, were assessed. The RB, BR, and SL phenolic extracts were successfully encapsulated. The RB, BR, and SL complex coacervates had no impact on the chemical composition of UF cheese. The structure of the RB, BR, and SL complex coacervates in UF cheese was the most stable. The hardness of UF cheese was progressively enhanced by using the RB, BR, and SL complex coacervates. The sensory characteristics of the UF cheese samples achieved good scores and were viable for inclusion in food systems. Additionally, these microcapsules improved metabolic strategies and neurobehavioral systems and enhanced the protein biosynthesis of rat brains. Both forms failed to induce any severe side effects in any experimental group. It can be concluded that the microencapsulation of plant phenolic extracts using a complex coacervation technique protected rats against AlCl3-induced neuroinflammation. This finding might be of interest to food producers and researchers aiming to deliver natural bioactive compounds in the most acceptable manner (i.e., food).
Collapse
Affiliation(s)
- Tarek N. Soliman
- Dairy Department, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
| | - Dina Mostafa Mohammed
- Department of Nutrition and Food Sciences, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
| | - Tamer M. El-Messery
- Dairy Department, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
| | - Mostafa Elaaser
- Dairy Department, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
| | - Ahmed A. Zaky
- Department of Food Technology, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
- *Correspondence: Ahmed A. Zaky,
| | - Jong-Bang Eun
- Department of Food Science and Technology, Chonnam National University, Gwangju, South Korea
| | - Jae-Han Shim
- Natural Products Chemistry Laboratory, Biotechnology Research Institute, Chonnam National University, Gwangju, South Korea
- Jae-Han Shim,
| | - Marwa M. El-Said
- Dairy Department, Food Industries and Nutrition Research Institute, National Research Centre, Cairo, Egypt
- Marwa M. El-Said,
| |
Collapse
|
39
|
Szczepańska E, Białek-Dratwa A, Janota B, Kowalski O. Dietary Therapy in Prevention of Cardiovascular Disease (CVD)—Tradition or Modernity? A Review of the Latest Approaches to Nutrition in CVD. Nutrients 2022; 14:nu14132649. [PMID: 35807830 PMCID: PMC9268367 DOI: 10.3390/nu14132649] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Revised: 06/19/2022] [Accepted: 06/22/2022] [Indexed: 02/06/2023] Open
Abstract
The development of cardiovascular diseases is undoubtedly influenced by improper dietary behavior. The most common mistakes include irregularity of meal consumption, high dietary atherogenicity: snacking on sweets between meals, low supply of dietary fiber, unsaturated fatty acids, legume seeds, and high supply of meat and meat products. Among many food components, some are characterized by a specific cardioprotective effect, which means that their supply of food may prevent the occurrence of cardiovascular disease or improve the health of the sick. Coenzyme Q10 (CoQ10) is one of the ingredients showing cardioprotective effects on the heart and blood vessels. Antioxidant and lipid profile-enhancing effects are also attributed to sitosterol which is one of the plant-derived sterols. A very important argument indicating the necessity of a varied diet rich in a variety of plant products is the beneficial effect of polyphenols, which are most abundant in multicolored vegetables and fruits. Numerous studies show their effectiveness in lowering blood pressure, improving lipid profile, and regeneration of vascular endothelium. The collected publications from the field of lifestyle medicine can be a source of knowledge for dieticians, physicians, and people associated with physical culture and human mental health to prevent the development of cardiovascular diseases and reduce the risk of death from this cause.
Collapse
Affiliation(s)
- Elżbieta Szczepańska
- Department of Human Nutrition, Department of Dietetics, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, ul. Jordana 19, 41-808 Zabrze, Poland; (E.S.); (O.K.)
| | - Agnieszka Białek-Dratwa
- Department of Human Nutrition, Department of Dietetics, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, ul. Jordana 19, 41-808 Zabrze, Poland; (E.S.); (O.K.)
- Correspondence: ; Tel.: +48-(0-32)-275-51-95
| | - Barbara Janota
- Doctoral School of the Medical University of Silesia in Katowice, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, ul. Piekarska 18, 41-902 Bytom, Poland;
| | - Oskar Kowalski
- Department of Human Nutrition, Department of Dietetics, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, ul. Jordana 19, 41-808 Zabrze, Poland; (E.S.); (O.K.)
- Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases, ul. Marii Curie-Skłodowskiej 9, 41-800 Zabrze, Poland
| |
Collapse
|
40
|
Çiftçi S, Suna G. Functional Components of Peanuts (Arachis Hypogaea L.) and Health Benefits: A Review. FUTURE FOODS 2022. [DOI: 10.1016/j.fufo.2022.100140] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
41
|
To J, Shao ZY, Gandawidjaja M, Tabibi T, Grysman N, Grossberg GT. Comparison of the Impact of the Mediterranean Diet, Anti-Inflammatory Diet, Seventh-Day Adventist Diet, and Ketogenic Diet Relative to Cognition and Cognitive Decline. Curr Nutr Rep 2022; 11:161-171. [PMID: 35347664 DOI: 10.1007/s13668-022-00407-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/07/2022] [Indexed: 11/28/2022]
Abstract
PURPOSE OF REVIEW Increasing evidence points toward the importance of diet and its impact on cognitive decline. This review seeks to clarify the impact of four diets on cognition: the Mediterranean diet, the anti-inflammatory diet, the Seventh Day Adventist diet, and the Ketogenic diet. RECENT FINDINGS Of the diets reviewed, the Mediterranean diet provides the strongest evidence for efficacy. Studies regarding the anti-inflammatory diet and Seventh Day Adventist diet are sparse, heterogeneous in quality and outcome measurements, providing limited reliable data. There is also minimal research confirming the cognitive benefits of the Ketogenic diet. Increasing evidence supports the use of the Mediterranean diet to reduce cognitive decline. The MIND-diet, a combination of the Mediterranean and DASH diets, seems especially promising, likely due to its anti-inflammatory properties. The Ketogenic diet may also have potential efficacy; however, adherence in older populations may be difficult given frequent adverse effects. Future research should focus on long-term, well-controlled studies confirming the impact of various diets, as well as the combination of diets and lifestyle modification.
Collapse
Affiliation(s)
- Jennifer To
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA
| | - Zi Yi Shao
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA
| | - Monique Gandawidjaja
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA
| | - Tara Tabibi
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA
| | - Noam Grysman
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA.
| | - George T Grossberg
- Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, 1438 South Grand Blvd, St. Louis, MO, 63104, USA
| |
Collapse
|
42
|
Abstract
PURPOSE OF REVIEW Nutrition is a complex exposure (i.e., the food exposome) that influences brain function and health through multiple pathways. We review recent epidemiological studies that have improved the characterization of the food exposome and brain health in humans and have revealed promising nutrition-based strategies to prevent cognitive aging. RECENT FINDINGS A selection of epidemiological research from the past 18 months of both observational and clinical studies is presented, with a focus on novel findings, including novel nutrient and diet patterns, diet-related approaches to rescue brain energetics defects in aging, and biomarker-based studies to decipher specific neurobiological pathways of nutrition and brain health. SUMMARY Although healthy diets such as the Mediterranean diet promote brain health throughout life, specific diets, such as the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay diet, or specific nutrients (LC n-3 polyunsaturated fatty acids, carotenoids, vitamin D, B vitamins, polyphenols) alone or in combination, may prevent cognitive aging. Diet management approaches to rescue brain energetics defects such as the Modified Mediterranean-ketogenic diet may be promising to prevent neurodegenerative diseases. Expanding research also suggests that promotion of a healthy gut microbiome through prebiotic foods may preserve the diet-gut-brain axis with aging. Future studies should explore more individualized preventive approaches through a 'precision nutrition' framework.
Collapse
|
43
|
Gregorevic K. Diet in the Prevention of Dementia. Psychiatr Ann 2022. [DOI: 10.3928/00485713-20220126-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
44
|
Amiri M, Li J, Roy S. Meal Planning for Alzheimer's Disease Using an Ontology-Assisted Multiple Criteria Decision-Making Approach. INTERNATIONAL JOURNAL OF E-HEALTH AND MEDICAL COMMUNICATIONS 2022. [DOI: 10.4018/ijehmc.316133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
As healthy diets and nutrition are crucial for people with Alzheimer's disease (AD), caregivers of patients with AD need to provide a balanced diet with the correct nutrients to boost the health and well-being of patients. However, this is challenging as they are likely to suffer from aging-related problems (such as teeth or gum problems) that make eating more uncomfortable; the planners, who are usually patients' family members, generally face high pressure, a busy schedule, and little experience. To help unprofessional caregivers of AD plan meals with the right nutrition and flavors, in this paper, the authors propose a meal planning mechanism that uses a multiple criteria decision-making approach to integrate various factors that affect a caregiver's choice of meals for AD patients. Ontology-based knowledge has been used to model personal preferences and characteristics and customize general diet recommendations. Case studies have demonstrated the feasibility and usability of the proposed approach.
Collapse
Affiliation(s)
| | - Juan Li
- North Dakota State University, USA
| | | |
Collapse
|
45
|
Maiuolo J, Gliozzi M, Carresi C, Musolino V, Oppedisano F, Scarano F, Nucera S, Scicchitano M, Bosco F, Macri R, Ruga S, Cardamone A, Coppoletta A, Mollace A, Cognetti F, Mollace V. Nutraceuticals and Cancer: Potential for Natural Polyphenols. Nutrients 2021; 13:nu13113834. [PMID: 34836091 PMCID: PMC8619660 DOI: 10.3390/nu13113834] [Citation(s) in RCA: 57] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 10/20/2021] [Accepted: 10/25/2021] [Indexed: 12/14/2022] Open
Abstract
Cancer is one of the leading causes of death globally, associated with multifactorial pathophysiological components. In particular, genetic mutations, infection or inflammation, unhealthy eating habits, exposition to radiation, work stress, and/or intake of toxins have been found to contribute to the development and progression of cancer disease states. Early detection of cancer and proper treatment have been found to enhance the chances of survival and healing, but the side effects of anticancer drugs still produce detrimental responses that counteract the benefits of treatment in terms of hospitalization and survival. Recently, several natural bioactive compounds were found to possess anticancer properties, capable of killing transformed or cancerous cells without being toxic to their normal counterparts. This effect occurs when natural products are associated with conventional treatments, thereby suggesting that nutraceutical supplementation may contribute to successful anticancer therapy. This review aims to discuss the current literature on four natural bioactive extracts mostly characterized by a specific polyphenolic profile. In particular, several activities have been reported to contribute to nutraceutical support in anticancer treatment: (1) inhibition of cell proliferation, (2) antioxidant activity, and (3) anti-inflammatory activity. On the other hand, owing to their attenuation of the toxic effect of current anticancer therapies, natural antioxidants may contribute to improving the compliance of patients undergoing anticancer treatment. Thus, nutraceutical supplementation, along with current anticancer drug treatment, may be considered for better responses and compliance in patients with cancer. It should be noted, however, that when data from studies with bioactive plant preparations are discussed, it is appropriate to ensure that experiments have been conducted in accordance with accepted pharmacological research practices so as not to disclose information that is only partially correct.
Collapse
Affiliation(s)
- Jessica Maiuolo
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Micaela Gliozzi
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Cristina Carresi
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Vincenzo Musolino
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Francesca Oppedisano
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Federica Scarano
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Saverio Nucera
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Miriam Scicchitano
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Francesca Bosco
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Roberta Macri
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
| | - Stefano Ruga
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
| | - Antonio Cardamone
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
| | - Annarita Coppoletta
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
| | - Annachiara Mollace
- Medical Oncology 1, Regina Elena National Cancer Institute, IRCCS, 00144 Rome, Italy; (A.M.); (F.C.)
| | - Francesco Cognetti
- Medical Oncology 1, Regina Elena National Cancer Institute, IRCCS, 00144 Rome, Italy; (A.M.); (F.C.)
| | - Vincenzo Mollace
- IRC-FSH Department of Health Sciences, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy; (J.M.); (M.G.); (C.C.); (V.M.); (F.O.); (F.S.); (S.N.); (M.S.); (F.B.); (R.M.); (S.R.); (A.C.); (A.C.)
- Nutramed S.c.a.r.l, Complesso Ninì Barbieri, Roccelletta di Borgia, 88021 Catanzaro, Italy
- IRCCS San Raffaele, Via di Valcannuta 247, 00133 Rome, Italy
- Correspondence:
| |
Collapse
|
46
|
Halloway S, Dhana K, Desai P, Agarwal P, Holland T, Aggarwal NT, Evers J, Sacks FM, Carey VJ, Barnes LL. Free-Living Standing Activity as Assessed by Seismic Accelerometers and Cognitive Function in Community-Dwelling Older Adults: The MIND Trial. J Gerontol A Biol Sci Med Sci 2021; 76:1981-1987. [PMID: 33835152 PMCID: PMC8562393 DOI: 10.1093/gerona/glab106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Few older adults are able to achieve recommended levels of moderate-vigorous physical activity despite known cognitive benefits. Alternatively, less intense activities such as standing can be easily integrated into daily life. No existing study has examined the impact of free-living standing activity during daily life as measured by a device on cognition in older adults. Our purpose was to examine the association between free-living standing activity and cognitive function in cognitively healthy older adults. METHOD Participants were 98 adults aged 65 years or older from the ongoing MIND trial (NCT02817074) without diagnoses or symptoms of mild cognitive impairment or dementia. Linear regression analyses tested cross-sectional associations between standing activity (duration and intensity from the MoveMonitor+ accelerometer/gyroscope) and cognition (4 cognitive domains constructed from 12 cognitive performance tests). RESULTS Participants were on average 69.7 years old (SD = 3.7), 69.4% women, and 73.5% had a college degree or higher. Higher mean intensity of standing activity was significantly associated with higher levels of perceptual speed when adjusting for age, gender, and education level. Each log unit increase in standing activity intensity was associated with 0.72 units higher of perceptual speed (p = .023). When we additionally adjusted for cognitive activities and moderate-vigorous physical activity, and then also for body mass index, depressive symptoms, prescription medication use, and device wear time, the positive association remained. CONCLUSIONS These findings should be further explored in longitudinal analyses and interventions for cognition that incorporate small changes to free-living activity in addition to promoting moderate-vigorous physical activity.
Collapse
Affiliation(s)
- Shannon Halloway
- Rush University College of Nursing, Rush University
Medical Center, Chicago, Illinois, USA
| | - Klodian Dhana
- Rush Institute for Healthy Aging, Rush University Medical
Center, Chicago, Illinois, USA
- Department of Internal Medicine, Rush University Medical
Center, Chicago,
Illinois, USA
| | - Pankaja Desai
- Rush Institute for Healthy Aging, Rush University Medical
Center, Chicago, Illinois, USA
- Department of Internal Medicine, Rush University Medical
Center, Chicago,
Illinois, USA
| | - Puja Agarwal
- Department of Internal Medicine, Rush University Medical
Center, Chicago,
Illinois, USA
- Rush Alzheimer’s Disease Center, Rush University
Medical Center, Chicago, Illinois, USA
| | - Thomas Holland
- Rush Institute for Healthy Aging, Rush University Medical
Center, Chicago, Illinois, USA
- Department of Internal Medicine, Rush University Medical
Center, Chicago,
Illinois, USA
| | - Neelum T Aggarwal
- Rush Alzheimer’s Disease Center, Rush University
Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, Illinois, USA
| | | | - Frank M Sacks
- Department of Nutrition, Harvard T.H. Chan School of
Public Health, Boston, Massachusetts,
USA
| | - Vincent J Carey
- Channing Division of Network Medicine, Brigham and
Women’s Hospital, Harvard Medical School, Boston,
Massachusetts, USA
| | - Lisa L Barnes
- Rush Alzheimer’s Disease Center, Rush University
Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, Illinois, USA
| |
Collapse
|
47
|
Ramadan MM, El‐Said MM, El‐Messery TM, Mohamed RS. Development of flavored yoghurt fortified with microcapsules of triple omega 3‐ 6‐ 9 for preventing neurotoxicity induced by aluminum chloride in rats. J FOOD PROCESS PRES 2021. [DOI: 10.1111/jfpp.15759] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Manal M. Ramadan
- Chemistry of Flavour and Aroma Department National Research Centre Cairo Egypt
| | | | | | - Rasha S. Mohamed
- Nutrition and Food Sciences Department National Research Centre Cairo Egypt
| |
Collapse
|
48
|
Liu X, Dhana K, Furtado JD, Agarwal P, Aggarwal NT, Tangney C, Laranjo N, Carey V, Barnes LL, Sacks FM. Higher circulating α-carotene was associated with better cognitive function: an evaluation among the MIND trial participants. J Nutr Sci 2021; 10:e64. [PMID: 34527222 PMCID: PMC8411267 DOI: 10.1017/jns.2021.56] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 07/21/2021] [Indexed: 01/28/2023] Open
Abstract
There is emerging evidence linking fruit and vegetable consumption and cognitive function. However, studies focusing on the nutrients underlying this relationship are lacking. We aim to examine the association between plasma nutrients and cognition in a population at risk for cognitive decline with a suboptimal diet. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) trial is a randomized controlled intervention that examines the effects of the MIND diet to prevent cognitive decline. The primary outcome is global cognition. A multivariate linear model was used to investigate the association between blood nutrients and global and/or domain-specific cognition. The model was adjusted for age, sex, education, study site, smoking status, cognitive activities and physical activities. High plasma α-carotene was associated with better global cognition. Participants in the highest tertile of plasma α-carotene had a higher global cognition z score of 0⋅17 when compared with individuals in the lowest tertile (P 0⋅002). Circulating α-carotene levels were also associated with higher semantic memory scores (P for trend 0⋅007). Lutein and zeaxanthin (combined) was positively associated with higher semantic memory scores (P for trend 0⋅009). Our study demonstrated that higher α-carotene levels in blood were associated with higher global cognition scores in a US population at risk for cognitive decline. The higher α-carotene levels in blood reflected greater intakes of fruits, other types of vegetables and lesser intakes of butter and margarine and meat. The higher circulating levels of lutein plus zeaxanthin reflected a dietary pattern with high intakes of fruits, green leafy, other vegetables and cheese, and low consumption of fried foods. Objective nutrient markers in the blood can better characterize dietary intake, which may facilitate the implementation of a tailored dietary intervention for the prevention of cognitive decline.
Collapse
Affiliation(s)
- Xiaoran Liu
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA
| | - Klodian Dhana
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA
| | - Jeremy D. Furtado
- Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
| | - Puja Agarwal
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA
| | - Neelum T. Aggarwal
- Rush Alzheimer's disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurology, Rush University Medical Center, Chicago, IL, USA
| | - Christy Tangney
- Department of Preventive Medicine, Rush Medical College, Chicago, IL, USA
- Department of Clinical Nutrition, Rush College of Health Sciences, Chicago, IL, USA
| | - Nancy Laranjo
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Vincent Carey
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Lisa L. Barnes
- Rush Alzheimer's disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurology, Rush University Medical Center, Chicago, IL, USA
| | - Frank M. Sacks
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
| |
Collapse
|
49
|
Malavolti M, Naska A, Fairweather-Tait SJ, Malagoli C, Vescovi L, Marchesi C, Vinceti M, Filippini T. Sodium and Potassium Content of Foods Consumed in an Italian Population and the Impact of Adherence to a Mediterranean Diet on Their Intake. Nutrients 2021; 13:2681. [PMID: 34444841 PMCID: PMC8401684 DOI: 10.3390/nu13082681] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Revised: 07/20/2021] [Accepted: 07/30/2021] [Indexed: 12/25/2022] Open
Abstract
High sodium and low potassium intakes are associated with increased levels of blood pressure and risk of cardiovascular diseases. Assessment of habitual dietary habits are helpful to evaluate their intake and adherence to healthy dietary recommendations. In this study, we determined sodium and potassium food-specific content and intake in a Northern Italy community, focusing on the role and contribution of adherence to Mediterranean diet patterns. We collected a total of 908 food samples and measured sodium and potassium content using inductively coupled plasma mass spectrometry. Using a validated semi-quantitative food frequency questionnaire, we assessed habitual dietary intake of 719 adult individuals of the Emilia-Romagna region. We then estimated sodium and potassium daily intake for each food based on their relative contribution to the overall diet, and their link to Mediterranean diet patterns. The estimated mean sodium intake was 2.15 g/day, while potassium mean intake was 3.37 g/day. The foods contributing most to sodium intake were cereals (33.2%), meat products (24.5%, especially processed meat), and dairy products (13.6%), and for potassium they were meat (17.1%, especially red and white meat), fresh fruits (15.7%), and vegetables (15.1%). Adherence to a Mediterranean diet had little influence on sodium intake, whereas potassium intake was greatly increased in subjects with higher scores, resulting in a lower sodium/potassium ratio. Although we may have underestimated dietary sodium intake by not including discretionary salt use and there may be some degree of exposure misclassification as a result of changes in food sodium content and dietary habits over time, our study provides an overview of the contribution of a wide range of foods to the sodium and potassium intake in a Northern Italy community and of the impact of a Mediterranean diet on intake. The mean sodium intake was above the dietary recommendations for adults of 1.5-2 g/day, whilst potassium intake was only slightly lower than the recommended 3.5 g/day. Our findings suggest that higher adherence to Mediterranean diet patterns has limited effect on restricting sodium intake, but may facilitate a higher potassium intake, thereby aiding the achievement of healthy dietary recommendations.
Collapse
Affiliation(s)
- Marcella Malavolti
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Androniki Naska
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Mikras Asias 75, 11527 Athens, Greece;
| | - Susan J. Fairweather-Tait
- Norwich Medical School, University of East Anglia, Norwich Research Park, James Watson Road, Norwich NR4 7UQ, UK;
| | - Carlotta Malagoli
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Luciano Vescovi
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| | - Cristina Marchesi
- Head Office, Direzione Generale, Azienda USL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy;
| | - Marco Vinceti
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
- Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
| | - Tommaso Filippini
- Environmental, Genetic and Nutritional Epidemiology Research Center (CREAGEN), Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; (M.M.); (C.M.); (L.V.); (T.F.)
| |
Collapse
|
50
|
Duplantier SC, Gardner CD. A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline. Nutrients 2021; 13:nu13072264. [PMID: 34208980 PMCID: PMC8308213 DOI: 10.3390/nu13072264] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 06/25/2021] [Accepted: 06/25/2021] [Indexed: 12/18/2022] Open
Abstract
Alzheimer’s disease (AD) and other dementias are now the seventh leading cause of death in the world and are projected to affect 115.4 million people by 2050. Delaying the onset of AD by just five years is estimated to reduce the cost and prevalence of the disease by half. There is no cure for AD nor any drug therapies to halt its progression once the disease begins. Lifestyle choices including diet are being seen as a viable complementary therapy to reduce cognitive decline, the hallmark of AD. Mediterranean, DASH (Dietary Approaches to Stop Hypertension), and MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diets have biological mechanisms supporting their potential neuroprotective benefits, but the findings of study outcomes about these benefits have been inconsistent. This paper analyzed five Randomized Clinical Trials (RCTs) (from 2000 to 2021) and 27 observational studies (from 2010 to 2021) focused on the link between cognitive health and the Mediterranean/DASH/MIND diets to identify gaps and challenges that could lead to inconsistent results. These include a lack of accuracy in assessing food intake, multiple dietary pattern scoring systems, a shifting metric among studies focused on the Mediterranean diet, a lack of standards in the tools used to assess cognitive decline, and studies that were underpowered or had follow-up periods too short to detect cognitive change. Insights from these gaps and challenges are summarized in recommendations for future RCTs, including both pragmatic and explanatory RCTs.
Collapse
Affiliation(s)
- Sally C. Duplantier
- The USC Leonard School of Gerontology, University of Southern California, 3715 McClintock Ave., Los Angeles, CA 90089, USA;
| | - Christopher D. Gardner
- Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA
- Correspondence:
| |
Collapse
|